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Canine osteoarthritis (OA) is a progressive and chronic disease that results in the destruction 
and deterioration of the cartilage surrounding synovial joints. It frequently presents with pain 
and lameness in dogs and can result in euthanasia. However, the pathogenesis and 
epidemiology of OA is poorly described in current literature. The aim of this study was to 
identify epidemiological information of OA such as the prevalence, severity, duration and 
risk factors contributing to the development of canine OA. This study also aimed to 
investigate how frequently relevant behavioural signs are recorded in primary care 
consultations and what pain-related behaviours dogs with OA exhibit. Firstly, the scientific 
literature was systematically searched following PRISMA (2009) guidelines, to produce a 
systematic review and meta-analysis on the risk factors that contribute to OA and its 
predisposing conditions. The second study included a cohort epidemiological study using 
primary care data from the VetCompass database combined with a case-control risk analysis 
to support the systematic review. In total forty-four papers were included in the final corpus 
of the systematic review, and four datasets were included in the meta-analysis. For the cohort 
study overall, 455,557 dogs were included in the study as a denominator population. 16,437 
candidate OA cases were identified, of which 6102 (37%) were manually checked and 4196 
were confirmed as osteoarthritis cases. The main findings in the systematic review showed 
OA is largely a genetic disorder exacerbated through lifestyle. The meta-analysis results 
showed females had greatest odds of developing cruciate ligament diseases (fixed effect odds 
(FE) 1.715, 95% confidence intervals (CI) 1.31 to 2.24; random effect odds (RE) 1.600, 95% 
CI 1.10 to 2.33) and hip and elbow dysplasia (FE 1.173, 95% CI 0.978 to 1.407; RE 1.129, 
95% CI 0.777 to 1.640), and that males have greatest odds of developing OA (FE 2.489 95% 
CI 1.253 to 4.943; RE 2.274 95% CI 0.707 to 7.309). In the epidemiological study an 
estimated prevalence for OA was calculated at 2.5%, and average duration of OA was found 
to be 2 years, presenting for 11% of life. The average severity was 6 (range 13), with obesity 
(p<0.001) and duration (p=0.018) significantly affecting severity score. 19.6 % of cases had 
at least one behavioural problem reported in the EPR, with the top 3 behaviours being dog is 
quieter, reluctance to exercise and alteration to normal behaviour. The main risks found in the 
risk analysis were age, insurance status and breed group (all p<0.001). This shows OA affects 
thousands of individuals and can have an incredibly long duration. It also showed that 
behaviour discussions were recorded in just under a fifth of cases. Further investigations are 
warranted in order to support this study as well as to reduce the number of cases of OA, as 
this disease can seriously impact canine welfare. 
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Chapter 1 
Introduction 
Epidemiological investigations and their importance 
Epidemiological investigations play an important role in both human and veterinary 
medicine, studying particular diseases within a certain population. These types of studies 
allow for prevalence estimates, disease prioritisation, severity and duration estimates, as well 
as identifying the risk factors that increase the likelihood of disease in order to allow for 
optimum treatment, prevention and control. They also improve our understanding of disease 
aetiology, which again is vital for control and prevention. These studies are common in 
human medicine and are becoming increasingly so in veterinary medicine in all fields. 
Veterinary studies are also an important contributor to public health, through the areas of 
zoonotic infections, medical research and animal health itself (Sargeant, 2008). The recent 
increasing interest in One Health, (an inter-disciplinary collaboration between the Food and 
Agriculture Organization, the World Health Organization, and the World Organisation for 
Animal Health) has potentially highlighted the role of dogs in human health (Gibbs, 2014). It 
has been suggested that while dogs can strongly help the support of, and also recovery from 
an ailment, ownership of a dog may also actually reduce illness both physically and 
psychologically in some cases. It has also been found that dogs can be used to detect a variety 
of ailments such as seizures, cancers, and hypoglycaemia, as well as provide relief to families 
with children with autism and are therefore very important in human medicine (Hall et al., 
2016 and Wells, 2007). Whilst these human-centric influences may act as a driver for animal 
studies, the key importance of animal health and welfare epidemiological studies is to predict, 
monitor and assess risk of welfare or health problems in animals.  
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A recent UK dog population survey showed that forty percent of UK homes own a pet, a 
quarter of which own a dog. The dog is the UK’s favourite pet with an estimated 8.5 million 
dogs owned (PFMA, 2016). Therefore, dog health studies are increasingly important. As a 
result of current and recent breeding practices, a reduction in dog health and welfare has 
occurred, prompting numerous studies into inherited defects of purebred dogs (Collins et al., 
2011 and Summers et al., 2010). It was found that fifty of the most popular breeds owned in 
the UK have a predisposition to at least one inherited health defect (Asher et al., 2009). This 
strongly warrants further research into a range of health disorders in order to reduce their 
impact on dog health and welfare.  
Risk factor analysis is an important epidemiological tool. Evaluating the role of ‘exposures’ 
in the development of a disease allows the identification, characterisation and quantification 
of risk factors that can potentially be controlled to prevent future cases of disease, and thus 
lower its welfare impact on a population (Blumenthal et al., 2001).  Another measurement of 
welfare risk assessment is the Welfare impact (WI). This can be calculated for dog health 
disorders in order to determine the overall impact on welfare the disorder poses using the 
prevalence estimate and severity of a disorder, in order to improve current management and 
strategies ultimately aiming to improve health and welfare. Calculation of welfare impact 
requires estimates of prevalence and severity to be made (WI= prevalence x severity) (Collins 
et al., 2010).  
Currently, there is a distinct absence of reliable prevalence data for many veterinary diseases 
and disorders, which makes the task of calculating reliable figures for the welfare impact of a 
disease on a population difficult. The prevalence of a disease is defined as the number of 
affected individuals within a population. A previous study has shown that only 1% of 
inherited canine diseases in the UK have published prevalence data (Collins et al., 2011). In 
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recent years, a number of projects have been established to attempt to collect data on a large-
scale, direct from veterinary practices.  These projects, which in the UK include 
VetCompass1 and SAVSNET2, ultimately allow for more accurate calculations of prevalence 
(O’Neill et al., 2014).  
Severity of a disease is another measure that can be used to show the impact of a disease on 
canine welfare. However, as a measurement it has a certain level of difficulty as methods of 
calculation are often subjective or use generic scales that may have aspects that are unrelated 
to particular diseases. Often these are stand-alone scales/scoring systems such as the General 
Illness Severity Index (GISID) (Asher et al., 2009), quality of life questionnaires (Freeman et 
al., 2005 and Wiseman-Orr et al., 2006), and pain assessment scoring systems such as the 
Canine Brief Pain Inventory (CBPI) (Brown et al., 2013). These scales are all very different 
to one another, and assess various aspects relating to the studied disorder. However, what 
they do have in common is the use of assessing deviations from the ‘norm’, which is where 
the individual is considered fit and healthy. Again, there is difficulty in this due to the lack of 
knowledge on pain experience in animals, and the variation in what the person assessing 
considers the ‘norm’, which could potentially be not healthy and fit at all (Packer et al., 
2012).  
Measuring duration provides another dimension in the characterisation of a disorder. In some 
diseases this is an easy measurement to make, such as acute disorders where there is a clear 
date of onset and end date. However, other disorders pose a greater difficulty, particularly 
chronic disorders where aetiology and pathological changes are not clear and can be gradual 
or have recurrent episodes.  There is also difficulty at an individual level, where it has been 
shown that pain expression differs with individual personality and therefore displaying of 
                                                             
1 See: http://www.rvc.ac.uk/VetCOMPASS 
2 See: https://www.liverpool.ac.uk/savsnet/ 
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signs of disease s at the onset of disease may differ significantly from one individual to the 
next and therefore not be recognised as the onset (Ijichi et al., 2014). In these cases, duration 
is more easily defined as time since diagnosis was made by the health-care professional 
(Davis et al., 2006), however this is not always completely reliable and there is risk of 
ambiguity, as the diagnosis may not actually be made until much later in disease progression.   
Duration estimates also depend upon the data provided and can vary greatly, particularly with 
primary care data, due to differences in duration from first signs shown by the individual to 
first signs witnessed by the owner to the actual date of diagnosis.  
Association of Pain-Causing Conditions and Behaviour 
Behaviour is currently a primary indicator of pain in veterinary medicine (Epstein et al., 
2015). Pain-causing health conditions are frequently associated with the performance of pain 
behaviours and so behaviours can be used to indicate level of pain severity, though this may 
be unreliable, as pain expression has been shown to vary with individual temperament (Ijichi 
et al 2014) Additionally, studies have shown that pain expression also varies with signalment 
factors such as age, sex and breed (Mathews et al., 2014). These behaviours may be 
exacerbated by stressors such as anxiety or fear, associated with the experience of pain.  
Behaviours seen as a result of pain include aggression, avoidance, attention-seeking 
behaviour, change in activity levels, and change in vocalisations (Epstein et al., 2015). For 
example, animals with debilitating diseases may show a decrease in vocalisations and show 
reluctance to move and therefore decreased activity (Epstein et al., 2015). Due to the nature 
of chronic diseases, behaviours associated with chronic pain are often subtle and slow to 
develop and therefore detection is more difficult. It is valuable to know the dog’s ‘normal’ 
behaviour and to recognise pain as the cause of any change (Mathews et al., 2014), as often 
euthanasia can result in behaviour cases. Studies are needed to identify particular behaviours 
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that can be associated with particular diseases so that practitioners can offer behavioural 
treatment as well as physical treatments, and their recognition can act as educational tools for 
owners recognising these behaviours in their dogs, as these are often the most likely people to 
identify an initial problem.  
Canine Health and Inherited Disorders 
After recent criticism of current breed standards and breeding practices, it has been brought 
to light that many breeds are predisposed to inherited defects. Breed conformation results in 
disorders in the majority of canine body systems, including cardiovascular, musculoskeletal, 
respiratory, immunological, gastrointestinal, endocrine, integumentary, urogenital and 
nervous / sensory (Asher et al., 2009). Dogs commonly suffer from a range of painful 
disorders linked in part to conformation and genetics, but also exacerbated through 
environmental factors. The musculoskeletal system is one of the most frequently affected 
systems, with large numbers of dogs experiencing varying levels of pain associated with 
conditions affecting this system (Johnson et al., 1994). Musculoskeletal disorders, whilst 
usually not immediately life threatening, can be extremely debilitating and chronic in 
duration and therefore significantly impact canine welfare, and can play a role in decisions on 
euthanasia.  
Canine Osteoarthritis 
Osteoarthritis (OA) is a well-known musculoskeletal condition seen in a wide range of 
species, from humans (Felson et al., 2000) to companion animals ranging from dogs to 
guinea pigs (Silverstein and Sokoloff, 1958). Often, OA develops from inherited disorders 
such as hip/elbow dysplasia and patellar luxation and so a strong link can be made to its 
development from genetic predisposition (Smith et al., 2001). Canine osteoarthritis occurs 
within the synovial joints, when the process of cartilage degeneration occurs at a faster rate 
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than the processes of regeneration and synthesis. It is chronic and progressive in nature, this 
ultimately results in degradation within the joint, accompanied by changes within the bone 
and formation of osteophytes (Alam et al., 2011). OA can arise in any joint but most 
commonly occurs in the hips, elbows, and stifles.  It is often associated with particular breeds 
and with older age, however, it can occur in any individual. OA is chronic and once a 
diagnosis is made, the condition is present until end of life. There is currently no curative 
treatment, so the focus is on palliative care and condition management.  These include weight 
and diet management, pain relief and structure modifying treatments (such as cartrophen) 
(Pettitt and German, 2015). Due to the lack of published epidemiological research on this 
debilitating condition, further investigation is needed for canine OA and therefore is the focus 
of this study. 
Hip and elbow dysplasia, cranial cruciate ligament rupture and patellar luxation are 
extensively discussed within the literature. It is frequently noted that these arthropathies often 
result in the development of OA due to the degradation of the joints each of the diseases 
presents within (Henrotin et al., 2005). Therefore, these conditions are included in the 
systematic review in chapter 2, as they are considered a risk for developing OA. Within the 
current literature other risks linking to the development of OA are explored and range from 
exercise and diet (Smith et al., 2006) to genetics as well as incorporating signalment aspects 
(Hays et al., 2007). Many studies investigate a particular risk only and therefore a full review 
of current risk factors for both OA and its predisposing condition is needed.  
Whilst it is discussed in current literature, prevalence estimates for OA vary widely and in the 
UK have been quoted from 6.6% (O’Neill et al., 2014) up to 20% (Johnston, 1997) in dogs 
>1 year of age.  It is obvious there is a large range of uncertainty in the actual prevalence rate 
of OA in the UK dog population and therefore this investigation aims to address this gap. 
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Due to the nature of OA, previously mentioned severity scales (Asher et al., 2009) are not 
suitable for its assessment and so development of an OA severity scale is needed.  Creating a 
scale for use within this study will be a secondary aim. Longitudinal studies have found OA 
duration can be long ranging, some studies show that it may first be present in young 
individuals (Smith et al., 2006).This study intends to use primary-care data in order to 
provide duration estimates and calculate percentage of life affected. 
Previous studies have reported behaviours related to OA using the CBPI (Brown et al., 2013). 
Both physical and psychological aspects of animal health and welfare should be taken into 
account when diagnosing and therefore it is important to understand the behaviours that 
exhibit with particular diseases. It has been discussed that during primary care consultations, 
behaviour is not talked about enough (Roshier and McBride, 2013a) and therefore this 
investigation is set out to determine the level of discussion of behaviour in primary care 
consultations as well as to identify the most frequently observed behaviours associated with 
OA. 
Study Aims and Objectives 
The aims of this investigation are to generate accurate epidemiological data on canine 
osteoarthritis in the UK dog population and to investigate its associated behaviours. This will 
be carried out through the following objectives: 1) Highlighting the main risk factors 
associated with the development of OA and its predisposing conditions; (2) Calculating the 
prevalence, severity and duration of OA and the types of behaviours exhibited within the UK 
dog population; and 3) Investigating the current management of OA in primary care practice. 
Objective 1 will be covered in chapter 2 and objectives 2 and 3 in chapter 3, followed by a 
discussion which will include the findings from both studies.    
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Chapter 2 
 
A Systematic Review and Meta-Analysis of Risk Factors Contributing to the 
Development of Canine Osteoarthritis and its Predisposing Conditions 
Abstract 
 
Canine osteoarthritis (OA) is the chronic destruction and deterioration of articular cartilage 
surrounding synovial joints. It is commonly associated with pain and lameness in dogs, but 
the pathogenesis and risk factors leading to OA development are poorly described. The main 
aim of this study was to highlight the key risk factors contributing to the development of 
canine OA and its predisposing conditions. The scientific literature was systematically 
searched on Web of Science and PubMed following PRISMA (2009) guidelines, generating 
broad searches using pre-specified combinations of key words. Forty-four papers met the 
inclusion criteria and were evaluated and graded against set criteria. Data extracted from four 
full datasets provided were included in a fixed-effects meta-analysis for sex on OA, cruciate 
ligament disease and hip and elbow dysplasia. The meta-analysis results showed females had 
greatest odds of developing cruciate ligament diseases (fixed effect odds (FE) 1.715, 95% 
confidence intervals (CI) 1.31 to 2.24; random effect odds (RE) 1.600, 95% CI 1.10 to 2.33) 
and hip and elbow dysplasia (FE 1.173, 95% CI 0.978 to 1.407; RE 1.129, 95% CI 0.777 to 
1.640), and that males have greatest odds of developing OA (FE 2.489 95% CI 1.253 to 
4.943; RE 2.274 95% CI 0.707 to 7.309).. Whilst some risk factors may be unavoidable, such 
as sex, others can be prevented or managed, which may significantly decrease cases of OA in 
the dog population.  This review provides a summary of the known risk factors associated 
with the development of OA and its predisposing conditions, identifying risks in the areas of 
genetics, (such as risk and protector genes) physiology, conformation (such as Norberg angle 
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and circumferential femoral head osteophytes) and environment and lifestyle (including age, 
sex and obesity). 
Introduction 
 
Osteoarthritis (OA) is a common pain-causing condition that affects millions of people 
worldwide (Felson et al., 2000), as well as many species of non-human animals. It has been 
reported in a range of species from small laboratory rodents (Silverstein and Sokoloff, 1958), 
across companion animal species, to larger mammals such as horses (Neil et al., 2005). 
Osteoarthritis (OA) also termed degenerative joint disease, is so-named due to the chronic 
and progressive destruction and deterioration of the articular cartilage surrounding synovial 
joints, resulting in joint degeneration commonly associated with pain (Runge et al., 2008).  
Risk factors for development of OA stem from both systemic and local causes such as 
genetics, age, sex, obesity and previous injuries (strains/tears) (Felson et al., 2000). The 
aetiology of OA remains uncertain.  
With over 8 million pet dogs owned in the UK (PFMA, 2016)3, the threat of OA to dogs is 
considerable. Canine OA is a major problem worldwide for veterinarians, owners and 
breeders alike, with prevalence in North America said to range from 20% of adult dogs up to 
80% of dogs over 8 years of age (Johnston, 1997).  Prevalence estimates for OA in the UK 
dog population vary widely, from 6.6% of dogs of any age and breed attending primary care 
practices, (O’Neill et al., 2014) up to 20% of dogs >1 year of age (Clements et al., 2010).   
Duration of OA has not been extensively explored in the literature, however a longitudinal 
study has found that OA can potentially be a lifelong condition, occurring from younger 
through to geriatric years (Smith et al., 2006), with an early study finding the average age of 
dogs affected by shoulder OA was 10.2 years (Ljunggren and Olsson, 1975). 
                                                             
3 See: http://www.pfma.org.uk/pet-population-2016 
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OA is typically categorised into two types, primary and secondary. Primary OA is idiopathic, 
with potential causative factors remaining largely unknown, however degeneration in such 
cases has been associated with ageing in dogs (Clements et al., 2006). Secondary OA results 
from disease or insult such as cruciate ligament injuries, osteochondritis dissecans (OCD), 
patellar luxation, dysplastic conditions, or direct injury/trauma, which often occur before the 
geriatric years (Hegemann et al., 2002).  
Cruciate ligament disease and rupture are common causes of pelvic limb lameness originating 
in the stifle joint in larger and giant breed dogs. Long-term degeneration caused by instability 
in the joint, can frequently lead to OA development (Taylor-Brown et al., 2015). Dysplasia 
typically occurs in the hip or elbow as a result of developmental malformation causing joint 
instability. This commonly leads to pain and lameness and often to laxity of the joint, causing 
further degeneration due to trauma (Worth et al., 2012). In many cases the pathogenesis of 
OA is said to have a genetic component, exacerbated through aspects of lifestyle, for example 
obesity (Smith et al., 2001).  
Currently there is no curative treatment for OA; rather interventions aim to alleviate pain and 
slow progression (Kealy et al., 2000). Interventions include weight and nutritional 
management, symptom modifying drugs (such as non-steroidal anti-inflammatory drugs-
NSAIDs, tramadol, and corticosteroids), and surgical intervention (Pettitt and German, 2015). 
Studies have shown that treatment with NSAIDs can significantly decrease the severity of 
pain associated with OA according to the Canine Brief Pain Inventory (Brown et al., 2008). 
Ultimately, preventative measures are the primary goal and further research is vital to deepen 
our understanding of the leading contributing factors to the development of OA.   
To date, an in-depth scope and analysis of risk factors for OA and its predisposing conditions 
is lacking.  This study aims to provide a comprehensive overview of all suggestive risk 
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factors that can be involved in the development of the most common forms of OA and its 
predisposing conditions, through systematic review and meta-analysis of published data. It is 
hypothesised that canine OA and its predisposing conditions will develop as a result of a 
combination of direct factors such as genetics that may be exacerbated by other factors 
related to the individual.  
Materials and Methods 
 
Literature Search 
The peer-reviewed literature was systematically searched for papers which included factors 
that influenced the development of OA and predisposing conditions, using the approach 
outlined by the PRISMA (2009) guidelines (Fig 1). The online databases Web of Science 
(WoS) and PubMed were used to generate broad searches using key words within logical 
sequences (Table 1: See appendix). All identified papers from each search were stored in a 
Microsoft Excel database.   
Literature searches were conducted during February and March 2016. Papers were initially 
sorted at Stage 1 by title, which had to include reference to dog/canine and OA or an 
associated disorder (listed in Table 1), with the implication that a risk factor was evaluated in 
the paper, with reference to words such as ‘prevalence’, ‘predictors’ or ‘susceptibility’.  Stage 
1 lists were independently evaluated by two reviewers, and inter-observer reliability 
calculated.   
At Stage 2, included papers followed an abstract check for suitability according to the 
evaluation criteria. Papers that passed the inclusion criteria moved to Stage 3, where the full 
article was read (Fig 1). All papers across all stages were stored on Microsoft Excel 
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spreadsheets for each stage of the systematic search and included author names, year of 
publication, title, journal, issue, volume and page numbers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finally, in Stage 4, additional papers were sourced from citations included in all Stage 3 
papers. Following these searches the papers were grouped according to the condition they 
Figure 1: Systematic Search Flowchart adapted from PRISMA Guidelines, 2009 
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were most relevant to and further divided into conformation, physiology, genetics and 
environment and lifestyle.  
Inclusion and Evaluation Criteria 
Peer-reviewed papers were included in the search with no timeframe filter implemented. 
Only papers either written in or translated into English were included in the search with no 
filters on country of origin of the literature. 
The evaluation criteria included: peer reviewed papers in English on the topic of OA 
(excluding reviews), which provided statistically supported risks or demonstration of an 
increase in a dog’s susceptibility to develop OA, such as (but not limited to) gene studies. 
Dogs included in the studies must have developed and been clinically diagnosed before or 
during the study or have radiographic evidence of early stage OA or one of its predisposing 
factors listed in the search terms. Studies could also include ‘healthy’ control cases.  
Study quality appraisal (QA) 
All of the included full text papers were subject to quality evaluation. The quality appraisal 
tool was created during this study based on recommendations from the Critical Appraisal 
Skills Program (CASP, UK) adapted to suit the variety of styles of studies identified during 
the literature search. The tool was adapted to assess study quality by evaluating 
methodological quality, (including biases) and outcomes/results of the studies to highlight the 
level of detail included within the paper (giving it a score of high: 7-10 [QA-H], medium: 4-6 
[QA-M], or low: 0-3 [QA-L]) (Table 2: See appendix).  
Finally, this was then combined in a Microsoft Excel spreadsheet along with title, authors and 
year, study design, statistical analysis used, results, the risk factors that the paper identified, 
overall sample (total number of dogs included in study) and control sample size (number of 
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control dogs) and whether power analysis was calculated and reported in the paper. The 
papers were grouped by individual disorder (See table 3). 
Statistical Analysis 
A fixed effect meta-analysis using the Mantel-Haenszel method for calculating the weighted 
pooled odds ratio was performed using MedCalc for Windows, version 16.4.3 (MedCalc 
Software, Ostend, Belgium).  Eighteen full datasets were requested by email from 
corresponding authors, for Stage 4 papers dated 2006-present.  Four datasets were provided 
(one of which was split into 4) whilst the other 14 were not provided due to the author no 
longer having access to the dataset (n=3), the supplied addresses were no longer active and no 
other provided (n=3) and a lack of response (n=8). Only sufficient data was provided to 
enable the analysis of sex as a risk factor. The result of sex on the odds of developing three 
disorders (OA (I2= 62%, 95% CI 0.0 to 91.3), Dysplasia (I2=48%, 95% CI 0.0 to 84.8) and 
CCL disease (I2=33%, 95% CI 0.0 to 97.8) were grouped onto forest plots and upper and 
lower confidence levels calculated.  
Results 
 
WoS generated 2141 papers, PubMed generated 604, once duplications were removed.  From 
the original search total, 432 paper titles were retained at Stage 1. At Stage 2, 194 abstracts 
were retained following the abstract check. In total, following stages 3 and 4, 44 papers met 
the inclusion and evaluation criteria for review (38 from WoS, 2 known to the authors, 1 from 
reference searches, 3 from the PubMed search. Note that 6 papers use the same data from a 
study on food restriction in a Labrador litter).  
Cruciate Ligament  
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There were 12 papers pertaining to risk factors involved in cruciate ligament disease and 
injury. Four papers were focussed on genetics (QA: 3H, 1M). Six papers were focussed on 
environment and lifestyle (QA: 6H). Two papers focussed on conformational risks (QA: 2H).  
Those as identified by the literature at greatest risk of developing cruciate diseases included: 
females (Whitehair et al., 1993; Adams et al., 2011; Taylor-Brown et al., 2015) (except 
bilateral rupture where males are more at risk (Grierson et al., 2011)) shown in the meta-
analysis (Fig 2a), neutered individuals (Whitehair et al., 1993; Clements et al., 2008; Duval et 
al., 2009; Adams et al., 2011; Taylor-Brown et al., 2015), breeds inclusive of but not limited 
to Rottweiler, Golden Retriever and Labrador Retriever (Grierson et al., 2011), and 
overweight/obese individuals (Whitehair et al., 1993; Grierson et al., 2011). Identification of 
genes and chromosomes associated with cruciate ligament disease were also highlighted 
(Clements et al., 2008; Wilke et al., 2009; Baird et al., 2014a; Baird et al., 2014b). Age was 
often a conflicting finding, with some studies suggesting higher risk in younger dogs, aged 1-
4 (Inauen et al., 2009), whilst others found older dogs >8 years (Taylor-Brown et al., 2015) to 
be more at risk.  
Dysplasia  
There were 16 papers in total associated with either hip or elbow dysplasia. One paper 
focussed on conformational risk factors (QA: 1H). Twelve papers focussed on environment 
and lifestyle (QA: 10H,2M). Three papers examined the genetics risk factors involved (QA: 
1H, 2M). Those at greatest risk of developing dysplasia as assessed by the papers included: 
neutered individuals (Witsberger et al., 2008; Torres de le Riva et al., 2013; Hart et al., 2014), 
individuals with: lower pelvic muscle mass (Cardinet et al., 1997), higher distraction index 
(Choi et al., 2008), greater weight (Priester and Mulvihill, 1972; Sallander et al., 2006) and 
non-restricted feeding (Kealy et al., 1992). Breeds experiencing high prevalence included 
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Mastiffs, Boxers, Italian Corso dog, Labrador and Golden retrievers (Lavrijsen et al., 2014b).  
Certain types of exercise, e.g. running after balls (Sallander et al., 2006), and particular risk 
and protector genes were also found (Clements et al., 2008; Lavrijsen et al., 2014a). There 
were some inconsistencies in results including month of birth, where all literature suggested 
being born in winter was a risk factor (Leppanen et al., 2000; Wood and Lakhani, 2003; 
Worth et al., 2012), though some also found being born in spring (Leppanen et al., 2000) or 
autumn (Worth et al., 2012) also increased the risk. Age was an inconsistent finding with 
papers varying in results with older dogs (>8 years) (Leppanen et al., 2000), 2months -1year 
or 1-4years (Witsberger et al., 2008) all quoted as risks among the literature.  Males were 
often quoted in the literature as being at greatest risk (Beuing et al., 2000; Witsberger et al., 
2008; Torres de le Riva et al., 2013; Hart et al., 2014), however other papers (Lavrijsen et al., 
2014b) as well as our meta-analysis results showed that females had greater odds of 
developing dysplasia (Fig 2b). 
OCD  
In total, 2 papers were identified by the systematic search relating to risk factors for OCD; 1 
genetic (QA: 1M) and 1 environment and lifestyle (QA: 1H). Risk factor findings in the OCD 
literature include: being male (Guthrie and Pidduck, 1990) and lifestyle factors such as 
drinking from well water (as opposed to city water), playing with other dogs’ daily and high 
dietary calcium (Slater et al., 1992). For patellar luxation, the literature indicated small breeds 
and females as most at risk; however, prevalence in larger dogs was noted to be increasing 
(Bound et al., 2009). 
Patellar Luxation  
One paper was identified by the systematic search relating to environment and lifestyle risks 
(QA: 1H).   
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Osteoarthritis  
Fourteen papers were identified for OA; 4 identifying risks pertaining to conformation (QA: 
4H), 3 physiology (QA: 3H), 5 environment and lifestyle (QA: 5H) and 2 genetics (QA: 1H, 
1M). The direct risks involved in developing OA are discussed fully below. 
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Table 3: Literature evaluation for all disorders 
Study 
authors and 
date 
Risk Factors Level of 
Detail 
(QA) 
Type 
of 
Study 
Overall 
Sample 
Size 
Control 
sample 
size 
 
Sample 
Size 
Calculated
? 
Cruciate Ligament Literature Evaluation 
 
Adams et al., 
2011 
Females H CC 1368 1179 N 
 Neutered      
 Rottweiler breed      
 Obesity      
 Older dogs (median 8 years)      
       
Baird et al., 
2014a 
Collagen genes significantly 
associated 
H CC 749 456 N 
       
Baird et al., 
2014b 
Associated regions on Chr 1, 3 & 
33 
H CC 271 172 N 
 Haplotype blocks on Chr 1 & 33      
 Association with SORCS2 gene      
       
Clements et 
al., 2008 
Neutered H CC 17 12 N 
 COL5A1 and RPL13A 
upregulated in 
     
 susceptible breeds      
 14 genes upregulated in rupture      
 2 genes down regulated in rupture      
       
Duval et al., 
1999 
Large breeds (9 predisposed) H CC 1005 804 N 
 Neutered      
 Greater body weight      
       
Grierson et 
al., 2011 
Rottweilers, golden & lab 
retrievers 
H CS 511 N/A N 
 Younger dogs (4.3 years)      
 Males      
 Overweight      
       
Inauen et al., 
2009 
Lower tibial tuberosity width H CS 219 73 N 
 Greater body weight      
 Larger proximal tibial tuberosity 
angle 
     
 Younger      
       
Morris and 
Lippowitz, 
2001 
Larger tibial plateau angle H C 87 31 N 
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Necas et al., 
2000 
Breeds: Am. Staff terrier, 
Rottweiler, 
H CS 183 N/A N 
 Chow chow, St Bernard, 
Bullmastiff, 
     
 Brazilian Fila, Lab retriever, Am. 
Cocker, 
     
 German shorthaired pointer, 
Boxer 
     
 Hyperextended pelvic stance      
       
Taylor-
Brown et al., 
2015 
Neutered H  CC 2,828 1,875 Y 
 > 3 years      
 Rottweiler & West Highland 
Terrier 
     
 Increasing body weight      
 Females      
       
Whitehair et 
al., 1993 
7-10 years H CC 602,317 591,548 N 
 Neutered      
 Females      
 Rottweiler, Newfoundlan, Staff 
terrier 
     
 Greater body weight      
       
Wilke et al., 
2009 
86 markers associated with CCLR 
traits 
M CS 90 N/A N 
 4 associated markers on chr 3, 5, 
13 and 24 
 
     
Dysplasia Literature Evaluation 
 
Beuing et al., 
2000 
Males H CS 2114 N/A N 
 Heritability estimate 0.28      
       
Cardinet et 
al., 1997 
Lower Pelvic muscle mass index H C 82 N/A N 
       
Choi et al., 
2008 
High distraction index M CS 87 N/A N 
 Greater weight      
 Dogs kept indoors through 
growth 
     
       
Clements et 
al., 2010 
10 SNPs as risk (5) or protector 
(5) genes 
M CC 647 438 N 
 8 haplotypes as risk (5) or 
protectors (3) 
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Kealy et al., 
1992 
Non-limited feeding H C 48 N/A N 
       
Krontveit et 
al., 2012 
Born Autumn and Winter H C 501 N/A N 
 Urban/ suburban home (breeder 
home) 
     
 exercise on soft ground, daily 
stair use 
     
       
Lavrijsen et 
al., 2014b  
Bullmastiff, Boxer and Italian 
corso dog most prevalent 
Females 
 
 
H CS 35,046 N/A N 
Lavrijsen et 
al., 2014a 
Associated regions on chr 1, 3, 5, 
8, 11, 12, 13, 15, 
H CC 122 NS N 
 19, 20 25, 28, 32, 34 and X 
chromosome 
     
       
Leppanen et 
al., 2000 
Born September - January H CS 10,335 N/A N 
 Older dogs      
       
       
Priester and 
Mulvihill, 
1972 
Large and Giant breeds H CS 1,193 N/A N 
       
Sallander et 
al., 2006 
Excersise by running after 
balls/sticks 
M CC 292 NS N 
 High fat intake/ energy from fat      
 Overfeeding/ High body weight      
       
Torres de la 
Riva et al., 
2013 
Early neutered males H C 1,518 N/A N 
       
Witsberger et 
al., 2008 
Neutered males H CS 1,243,68
1 
N/A N 
 2 months - 1 year and 1-4 years      
 Large and Giant breeds 
 
     
       
Wood and 
Lakhani, 
2003 
Born November to June (winter 
& spring) 
H CS 9,657 N/A N 
 Hip scores significantly 
correlated to relatives 
     
       
Worth et al., 
2012 
Born Winter or Spring H CS 5722 N/A N 
 
Osteochondritis Dissecans Literature Evaluation 
 
Guthrie and 
Pidduck, 
Males M CS 46 N/A N 
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1990 
 Multifactorial mode of 
inheritance 
     
 Higher heritability in males      
       
Slater et al., 
1992 
Drinking well water H CC 91 60 N 
 Playing with other dogs daily      
 Not fed specialty dry food      
 High dietary calcium 
 
     
Patellar Luxation Literature Evaluation 
 
Bound et al., 
2009 
Small breeds H CS & 
CC 
155 42 Y 
 Females      
 Larger breeds increasing 
 
     
Osteoarthritis Literature Evaluation 
 
Andrysíková 
et al., 2012 
High levels of GAGs H CC 36 5 N 
 Higher GAGs in obese dogs      
       
Grondalen 
and Lingaas, 
1991 
Males M CS 2,046 N/A N 
 Dogs with at least one parent with 
OA 
     
       
Hays et al., 
2007 
Males (increased hip score & risk 
of OA) 
H CS 137 N/A N 
 Additive inheritance      
       
Hegemann et 
al., 2002 
Synovial 5D4 and TIMP-1 
increased (ACLR) 
H CC 133 30 N 
 Higher serum 5D4 and 10 fold 
lower serum TIMP-1 levels (FPC) 
     
 Synovial 5D4 and TIMP-1 were 
upregulated in dogs (patellar 
luxation) 
     
 Synovial TIMP-1 increased in hip 
dysplasia 
     
       
Kealy et al., 
1997 
Non restricted feeding H C 48 N/A N 
 Greater norberg angle and early 
joint laxity 
     
       
Kealy et al., 
2000 
Higher body weight H C 48 N/A N 
 Non restricted feeding      
       
       
Maccoux et IL-1b expression in synovial fluid H CC 13 5 N 
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Meta-analysis  
4 study datasets (1 of which split into 4) were sent upon request and 1 paper provided enough 
information within the published article to be included within the meta-analysis. The forest 
plots demonstrate that females had greatest odds of developing cruciate ligament diseases  
and dysplasia, and that males have greatest odds of developing OA (Fig 2a-c), supported by 
Table 4- 6.  
al., 2007 and fat pad 
 IL-6 expression in synovial 
membrane 
     
 Control synovial membrane have 
higher level of IL-8 expression 
     
 IL-10 gene expression in synovial 
membrane 
     
       
Mayhew et 
al., 2002 
Caudolateral curvilinear 
osteophyte 
H CS 25,968 N/A N 
 Distraction index      
       
Powers et al., 
2004 
Caudolateral curvilinear 
osteophyte 
H C 48 N/A N 
 Non restricted feeding      
       
Runge et al., 
2008 
Non restricted feeding H C 48 N/A N 
       
       
Runge et al., 
2010 
High Distraction index H CS 4349 N/A N 
 Higher Weight      
 Older dogs      
       
Smith et al., 
2001 
High distraction index H CS 15,742 N/A N 
 Weight      
       
Smith et al., 
2006 
Non restricted feeding H C 48 N/A N 
       
Szabo et al., 
2007 
Circumferential femoral head 
osteophyte 
H C 48 N/A N 
 
 
aAbbreviations- C- Cohort;  CC- Case-control;  CS: Cross Sectional;  H- High;  L- Low; M- Medium;  N- No;  
N/A- Not Applicable;  NS- Not Stated; Y- Yes 
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Table 4: Odds, Upper and Lower Confidence intervals, z and P value and Fixed and 
Random weight (%) for cruciate ligament disease meta-analysis 
Study Odds ratio 95% CI z P Weight (%) 
Fixed Random 
Adams et al., 2011 1.974 1.430 to 2.725     69.27 54.81 
Torres de la Riva et al., 2013 1.047 0.540 to 2.032     16.42 23.77 
Torres de la Riva et al., 2013 1.497 0.736 to 3.044     14.31 21.42 
Total (fixed effects) 1.715 1.314 to 2.239 3.969 <0.001 100.00 100.00 
Total (random effects) 1.600 1.100 to 2.328 2.458 0.014 100.00 100.00 
 
 
Table 5: Odds, Upper and Lower Confidence intervals, z and P value and Fixed and 
Random weight (%) for dysplasia meta-analysis 
Study Odds ratio 95% CI z P Weight (%) 
Fixed Random 
Worth et al., 2012 1.215 0.995 to 1.485     83.20 55.42 
Torres de la Riva et al., 2013 1.745 0.804 to 3.787     5.56 17.17 
Torres de la Riva et al., 2013 0.741 0.430 to 1.279     11.23 27.41 
Total (fixed effects) 1.173 0.978 to 1.407 1.721 0.085 100.00 100.00 
Total (random effects) 1.129 0.777 to 1.640 0.638 0.523 100.00 100.00 
 
Table 6: Odds, Upper and Lower Confidence intervals, z and P value and Fixed and 
Random weight (%) for OA meta-analysis  
  
Study Odds ratio 95% CI z P Weight (%) 
Fixed Random 
Andrysikova et al., 2012 1.181 0.377 to 3.698     37.46 45.25 
Hays et al., 2007 3.908 1.615 to 9.457     62.54 54.75 
Total (fixed effects) 2.489 1.253 to 4.943 2.605 0.009 100.00 100.00 
Total (random effects) 2.274 0.707 to 7.309 1.379 0.168 100.00 100.00 
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Figure 2: Meta analysis showing: females have greatest odds for developing cruciate ligament 
diseases (a), females have greater odds for developing dysplasia (b) and males have greater 
odds for developing OA (c) 
 
Meta-analysis
0.1 1 10
Odds ratio
Adams et al., 2011
Torres de la Riva et al., 2013
Torres de la Riva et al., 2013
Total (fixed effects)
Total (random effects)
Meta-analysis
0.1 1 10
Odds ratio
Andrysikova et al., 2012
Hays et al., 2007
Total (fixed effects)
Total (random effects)
Meta-analysis
0.1 1 10
Odds ratio
Worth et al., 2012
Torres de la Riva et al., 2013
Torres de la Riva et al., 2013
Total (fixed effects)
Total (random effects)
a) 
b) 
c) 
29 
 
Discussion 
 
OA occurs as a result of trauma, disease or insult as well as a combination of factors specific 
to OA. Conditions such as hip dysplasia, patellar luxation, osteochondritis dissecans, 
fragmented coronoid process and cruciate ligament disease can all be considered a risk 
factors for developing OA in dogs and therefore the risks for developing these conditions are 
also indirect risks for OA development. Better understanding these conditions will contribute 
to identifying ‘at risk’ individuals, in order to reduce and prevent the occurrence of OA in 
dogs. However, whilst these diseases and traumas remain a risk, there are additional 
identified direct risks for the most common forms of OA relating to genetics, conformation, 
physiology and environment and lifestyle. 
Most cases of OA of the coxofemoral joint develops from hip dysplasia (Runge et al., 2010). 
Dogs with lower hip scores are significantly less likely to develop OA of the hip than those 
with higher scores (Hays et al., 2007), therefore this should be taken into account when 
selecting individuals for breeding (Wood et al., 2002). Both Norberg angle and distraction 
index have been significantly correlated with OA development. The distraction index is 
considered one of the greatest risk factors for OA, with the greater the score, the greater the 
risk. This is due to laxity in the joint resulting in damage and degradation often as a result of 
dysplasia (Kealy et al., 1997).  
A genetic component has been recognised for OA. Offspring are significantly more likely to 
develop OA if one or both parents also had OA compared to offspring that did not have any 
parents with OA (Grondalen and Lingaas, 1991). Therefore, dogs diagnosed with OA or a 
predisposing condition, or first degree relatives (sire/dam, siblings, offspring) of that 
individual, should not be bred from as these conditions have been shown to be inherited. If 
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importing sires or dams, it is important to know full details of background and relatives to the 
individual.   
Caudolateral curvilinear (CCO) and circumferential femoral head osteophytes can be used as 
early markers for predicting OA (Mayhew et al., 2002; Szabo et al., 2007), with a study 
showing that all dogs with a CCO were 3.7 times more likely to develop radiographic signs 
of OA than those without. Circumferential femoral head osteophytes have also been shown to 
be early markers of OA by Powers et al., (2004). Individuals with high hip scores should not 
be bred from, and dogs with early signs of OA such as CCO on radiographs should not be 
bred from either. Early detection of OA could prevent breeding from susceptible individuals, 
as many dogs will have been bred from before the condition was apparent. This will in turn 
reduce the number of offspring susceptible to OA, and therefore these early diagnostic tools 
as well as further research into susceptibility genes should be considered. 
Additional diagnostic tools which may aid in early diagnosis include assessing the presence 
of cytokines and other biomarkers. The pathway that disrupts the balance of degradation and 
repair is said to be mediated by cytokines, and therefore measurements of these could 
indicate whether certain individuals are at risk of developing OA. Interleukins were found to 
be heavily involved, with significant increase in expression of various ILs in fat pads and 
synovial fluid and membranes of individuals with OA (Maccoux et al., 2007). Expression of 
these cytokines could therefore be used to identify individuals that may be at risk of 
developing or progressing to OA from other conditions. 
Certain biomarkers have been identified in synovial fluid, membranes, urine and blood as 
early detectors of OA, which could aid diagnosis or prediction of OA. Glycosaminoglycan’s 
(GAGs) have been shown to be involved in the degradation of cartilage and therefore can 
lead to the development of or accelerate the development of OA (Andrysíková et al., 2012). 
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A study has shown that increased levels of GAGs have been found in obese dogs, which most 
likely leads to the development of OA (Andrysíková et al., 2012). Other studies noted 
biomarkers such as synovial and serum 5D4 and TIMP-1 being either increased or decreased 
in conditions such as hip dysplasia or fragmented coronoid process (Hegemann et al., 2002).   
Weight, age and sex are suggested as risks for developing OA.  The literature suggests males 
having the greatest risk of developing OA as well as suffering greater severity. This was 
supported by the meta-analysis which showed that males had greater odds of developing OA 
than females (Fig 2c). This could be due to sex hormone differences as well as differences in 
weight between males and females (Hays et al., 2007). However, the outcome of developing 
OA because of sex can be significantly affected by other covariates such as neuter status and 
this needs to be taken into account when studying the effect of sex on OA development. A 
study conducted using paired littermates, one of which was on a control diet and the other on 
a restricted diet (25% less food than the control), showed that more dogs in the control group 
had an increased body weight and significantly increased development of OA, which was 
also more severe. The onset of OA was significantly delayed in the group with restricted 
intake. This therefore shows that a lean body condition and therefore improved phenotype 
should be maintained throughout the dog’s life (Kealy et al., 1997). Despite the common 
association of OA with older dogs due to the natural progression of the disease and age 
related degeneration, a significant impact from diet was found from 1-5 years of age (Kealy 
et al., 1997). Restricted feeding has been shown to increase longevity of an animal which in 
turn could lead to age related degeneration and development of OA at an older age (Lawler et 
al., 2008; Runge et al., 2008).  
OA and its predisposing conditions are frequently diagnosed in veterinary medicine 
demonstrating that they can have a large impact on canine welfare. As well as being 
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debilitating to the dog itself these conditions can have a large impact on owners too. High 
costs are associated with the treatment of these conditions – for example $1.32 billion spent 
on cruciate ligament ailments alone in the US in a year (Baird et al., 2014b). Additionally, 
OA is commonly seen in larger breeds which are often used as working or service dogs, 
which again negatively impacts owners of these dogs should they need to be retired from 
service prematurely.  
The aim of this review was to collate all current information on the risk factors associated 
with developing OA and its predisposing conditions. The review showed that current 
literature, although fairly sparse, is mostly highly detailed in their descriptions of 
experimental method, and consistent across published results. This review highlighted clear 
gaps for further research in this area. 
Further research to understand the pathogenesis of OA and its predisposing conditions would 
be advantageous and may improve the understanding of risk factors that lead to development 
of the diseases and further clarify identified risk factors in the existing literature. A deeper 
understanding of the risk factors contributing to cruciate ligament disease and rupture, 
dysplasia (for example the impact of exercise on its development), patellar luxation (for 
example explaining increased prevalence in large breed dogs) and OCD as well as the 
development of genetic screening tests, mapping of significant SNPs and gene regions, and 
identifying gene functions would be particularly timely. Prevalence data of OA resulting 
from predisposing conditions is currently lacking as is research into the rate of development 
from a predisposing condition to OA. Different risks also need to be further explored in order 
to highlight their relative effect on disease development and severity, for example obesity vs 
age. Finally, further exploration into early detection and diagnosis is needed in order to 
reduce the number of affected individuals that are bred from. 
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Although systematic reviews and meta-analysis are considered the top evidence reporting 
articles, there are certain to be some limitations. Author misinterpretation of studies and data 
is always a possibility, along with human error in the systematic search which may result in 
some literature being missed from the search. The evaluation of the studies is again, very 
subjective and occasionally opinions may bias/differ from others, which should be kept in 
mind. Limiting the criteria to include published only articles could lead to publication bias 
and result in unreliable or exaggerated results. Whilst the methodology of this paper is that of 
the systematic review as set out by PRISMA guidelines, overall it acts as a scope of risk 
factors contributing to the most common forms of OA. Due to the large variation in the 
studies and their data, this review is unable to determine or list definitive causes of specific 
types of OA due to limited studies that use controls. 
In the case of this study, elbow and hip dysplasia’s were grouped together. As two separate 
conditions this could lead to some limitations in the results, as this study provides a general 
scope of the risks that contribute to the most common forms of dysplasia, rather than the 
specific risks contributing to each specific disorder. Therefore, in future it would be 
beneficial to separate these as two conditions.  
With regards to the meta-analysis, lack of data and absence of covariate variable data (e.g. 
neuter status when investigating effect of age on developing OA) could limit the outcomes of 
the study by affecting the results and the heterogeneity between datasets. Only a limited 
number of datasets were provided upon request and therefore study selection was limited and 
therefore may result in bias results. The heterogeneity of the datasets were all moderate 
according to the Cochrane Handbook, for Systematic Review Interventions (Version 5.1.0, 
2011). Due to only a few responses to request for datasets, only 2 or 3 datasets were used in 
each meta-analysis which could explain the moderate heterogeneity between the datasets. The 
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OA analysis had the greatest heterogeneity likely due to the fact it had the fewest datasets and 
therefore lowest power. However, it has been argued previously that due to diversity of 
datasets included in many studies that heterogeneity is often unavoidable, and therefore 
shouldn’t necessarily stop the analysis from being conducted (Higgins, 2003). 
Conclusion 
 
To the authors’ knowledge this is the first systematic review to produce a scope of risk 
factors for the most common forms of OA. This review provides a summary of published 
literature surrounding risk factors for OA and its predisposing conditions. OA is still too 
common within the dog population, and from the welfare and quality of life implications, 
prevalence reduction is important.  Whilst some risk factors may be unavoidable such as 
neuter status (in preventing unwanted pets and reducing the risk of diseases such as 
mammary cancer) and age, others can be managed, particularly lifestyle factors for example 
keeping susceptible individuals lean. Identifying risks including genetics and breed type can 
lead to effectively implementing schemes to reduce prevalence through not breeding from 
individuals with the condition through better education of breeders.  Additionally, better 
education of owners regarding breed selection and risk mitigation during ownership of their 
dog and finally improving advice and preventative treatment administered by vets will all 
increase dog welfare.   
The disease still remains incompletely explained and therefore needs further investigation to 
allow for more prevention and treatment options to include cure rather than simply palliation. 
A positive finding of the review is the high quality of evidence in the papers selected for 
review as well as the fact that there were consistent findings across papers. 
Acknowledgements  
35 
 
The authors would like to thank those who responded to the request for and provided full 
datasets for the meta-analysis in this study: Andrysikova et al., Worth et al., Hays et al., 
(Correspondence: Todhunter) and Torres de la Riva et al., (Correspondence: Hart).  
   
36 
 
Chapter 3 
Epidemiology of Canine Osteoarthritis (OA) in the UK Dog Population as Assessed at 
Primary Veterinary Consultations 
Abstract 
 
In order to prioritise welfare-diminishing diseases in veterinary medicine, reliable 
information on prevalence, severity, duration and other aspects are crucial. Osteoarthritis 
(OA) is the most common joint disease in both human and veterinary medicine, posing a 
considerable challenge to canine welfare, and therefore epidemiological investigation in this 
disease is warranted. The aims of this study were to evaluate the epidemiology and impact of 
OA in dogs, and to describe clinical diagnosis and management of OA in primary-care 
veterinary practice.  In order to investigate the psychological as well as physical impact of 
OA on quality of life, this study also aims to identify dog behaviours associated with OA. 
The VetCompass database was used to access clinical data from dogs attending primary-care 
veterinary practices in the UK. The study included all VetCompass dogs under veterinary 
care during 2013. Candidate OA cases were identified using a combination of search terms 
across the database and a random subset were then manually evaluated against a case 
definition. Of 455,557 study dogs, 16,437 candidate OA cases were identified of which 6104 
were manually checked and 4196 were confirmed as OA cases. Additional data on 
demography, clinical signs and management were obtained then exported for analysis. The 
estimated prevalence (accounting for subsampling) of OA was 2.48% (95% confidence 
interval: 2.44-2.53). The mean age of diagnosis of OA was 8.6 years (± 3.6yrs, SD). Of the 
OA cases 19.9% had at least one behavioural complaint, with quietness and reluctance to 
exercise reported most frequently, whilst 88% of OA cases were given at least one treatment 
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for OA. Results of epidemiological findings will be discussed in relation to the impact on 
canine welfare, and how these metrics can be used to prioritise OA in veterinary medicine.   
Introduction  
 
Osteoarthritis (OA) is the most commonly diagnosed joint disease in both human medicine 
and veterinary medicine (Mele, 2007). Osteoarthritis can be experienced as an extremely 
painful and sometimes debilitating condition (Pettitt and German, 2015).  It is characterised 
by the progressive degeneration of synovial joints which leads to the development of reduced 
joint movement and lameness in dogs, as well as the presence of osteophytes and 
inappropriate new bone formations (Alam et al., 2011).  The most frequently reported clinical 
and physical signs of OA in dogs include lameness, stiffness, reluctance to exercise and 
altered gait, all of which are suggestive of pain.  
Veterinary treatments for OA at best alleviative symptoms, as there is no current curative 
treatment available, therefore the condition typically deteriorates over time (Pettitt and 
German, 2015).  It is largely discussed as a multifactorial disease with a strong genetic 
component, exacerbated by aspects of lifestyle individual to each dog (Grondalen and 
Lingaas, 1991). OA occurs as a result of instability within the joint and is frequently 
associated with underlying conditions such as dysplasia, cruciate ligament rupture and 
osteochondritis dissecans, although it is not known what proportion of cases develop from 
these predisposing conditions (Rychel, 2010). The most common sites affected by OA 
include the stifles, hips and elbows. It is commonly considered a geriatric disease, although it 
can develop at any age; however, it is often only later in a dog’s life that OA is seen to be a 
more significant problem and thus diagnosed when mobility is significantly affected 
following progressive degeneration (Rychel, 2010). It is suggested that >50% of cases are 
diagnosed in dogs aged 8-13 years (Mele, 2007). Other studies suggest age of onset depends 
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on breed and size, with average age of onset in Rottweilers estimated as 3.5 years, but an 
average of 9.5 years reported in smaller breeds (Mele, 2007).  
Prevalence of OA is reported in the literature, but there are contradictions in the reports. 
Estimates have ranged from 6.6% from primary care data (O’Neill et al., 2014) to 20% 
(Pettitt and German, 2015) in the UK dog population. Estimates from North America report 
the prevalence to range from 20% in dogs >1 year, to 80% in dogs >8 years, of any breed 
(Johnston, 1997). 
The duration of time a dog is affected by OA is not well discussed in the published literature.  
OA can occur at any age, however OA may not be clinically diagnosed until a later stage and 
may therefore be recorded as having a shorter duration than actually experienced by the 
individual (Rychel, 2010). Due to the difficulty of pinpointing the onset of the disease, 
duration studies are very difficult to conduct. Another difficultly when trying to determine 
duration arises as many cases develop from conditions such as hip or elbow dysplasia or 
cruciate ligament rupture. Although degeneration of the joint is likely occurring from before 
the diagnosis of the initiating cause, as the anatomical diagnosis is likely to be the one first 
noted, OA may not be considered to be present until much later in the disease course. Despite 
these difficulties, longitudinal studies have demonstrated that OA can potentially be a 
lifelong condition for some dogs (Smith et al., 2006), but further investigation is needed in 
this area to further highlight the proportion of cases that occur at different age categories to 
better understand the impact on welfare of this condition.  
Measuring severity of diseases is complex and difficult.  Previous literature has used severity 
scales in order to characterise, quantify and compare the severity of different canine 
conditions. Asher et al. (2009) proposed the Generic Illness Severity Index (GISID) using 
data collected from published literature, for scoring diseases based on prognosis, treatment, 
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associated complications and how the dog’s behaviour has been impacted by the disease. 
Other studies use pain and behaviour scoring assessments through owner surveys in order to 
determine severity (Rialland et al., 2012); however, in the case of primary care data much of 
this is not explicitly recorded, and the complex nature of OA as a disease makes assessment 
of severity considerably harder. For this study, a novel calculation of severity was developed 
based on primary care data.  This approach is based on a combination of proxy measures 
specifically suited to primary care data, which are designed to map onto the previously 
published GISID scoring system (Asher et al., 2009).  
A broad range of pain associated behaviours have been discussed in the literature (Epstein et 
al., 2015), however little data exists regarding specific behaviours related to specific pain-
causing conditions.  Different individuals regulate chronic pain differently and can exhibit 
this in many ways such as through increased attachment to their owner, which may be 
considered a minor change in comparison to a change such as an increase in aggressive 
behaviour (Rutherford et al., 2012). It is the owner and veterinary professional’s 
responsibility to recognise any behavioural changes that may be associated with chronic pain 
conditions. Psychological and behavioural aspects that are associated with pain are often 
overlooked in primary care, with the physical problem being the main focus (Roshier and 
McBride, 2012a&b). Therefore, behavioural manifestations of pain are likely to be under 
reported in primary care notes.  
Under the Animal Welfare Act (2006), both physical and psychological aspects of a dog must 
be cared for (Section 4- Prevention of Harm). In the case of OA this means both the chronic 
pain and the associated behavioural manifestations need to be addressed. This highlights the 
importance of this investigation into the epidemiology, severity and behavioural aspects of 
OA due to the significant impact OA can have on canine welfare. 
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The aims of this study were (i) to calculate the prevalence, severity and duration of OA in the 
UK dog population from primary care data, and to identify if there are factors that affect 
severity score; (ii) to identify the risk factors for a diagnosis (in the case of this study, 
diagnosis refers to presumptive, radiographic or definitive diagnosis and excludes tentative or 
working diagnoses) of OA; (iii) to highlight how OA cases are clinically diagnosed and 
managed in practice; and (iv) to identify the most frequent behaviours associated with OA in 
order to investigate the psychological as well as physical impact of OA on quality of life. 
These aims will be answered using the following hypotheses: (i) prevalence of OA will be 
between 6 and 20% in the UK dog population; severity of OA will be affected by age, weight 
and breed differences and (ii) insurance status, age, sex, neuter status, and breed group are 
risks factors that increase the likelihood of an OA diagnosis. Aims (iii) and (iv) will be 
answered using descriptive analysis.  
Material and Methods 
 
Ethical approval was granted by the College of Science’s Ethics Committee at the University 
of Lincoln, UK in May 2016 (Reference number CoSREC125).  
The study made use of data collected by The VetCompass Animal Surveillance project. This 
project collated de-identified Electronic Patient Record (EPR) data from primary-care 
veterinary practices in the UK for epidemiological research (O’Neill et al., 2014). Practices 
volunteered to participate in the project and to allow the recording of their clinical data within 
an appropriately configured practice management system. Information collected related to the 
owned dog population and included patient demographic (species, breed, date of birth, sex, 
neuter status, insurance status and weight) and clinical information. Practitioners recorded 
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summary diagnosis terms from an embedded VeNom Code4 list (a standard set of clinical 
veterinary terms, used in referral veterinary hospital EPRs and first opinion veterinary 
practice management systems) during episodes of care as well as free-form text clinical 
notes, summary diagnosis terms, treatment and deceased status with relevant dates. EPR data 
were extracted from practice management systems using integrated clinical queries 
(Kearsley-Fleet et al., 2013) and uploaded to a secure VetCompass structured query language 
(SQL) database.   
Pilot Study 
Due to the large scale of the primary care dataset, initial pilot investigations were conducted. 
These were firstly run on the case definition which was decided after refinement using the 
information provided in the EPRs. A clear case definition was needed in order to reduce the 
number of false negatives and false positives, by excluding cases that were listed as 
differential diagnoses or other types of arthritis, such as auto-immune or septic. As many 
cases did not undergo imaging procedures, the case definition needed to be broadened to 
include other ways of determining OA cases, as a combination of signs and treatments.  
Pilot tests were also run on the search terms used to find the cases within the denominator 
population. An initial list of search terms was drawn up including disease terminology, 
symptoms and treatments to identify the candidate cases.  Terms were trialled multiple times 
and either kept or rejected based on their sensitivity and specificity. Terms were shortened 
and included the use of wildcards (e.g *) in order to allow for as many spelling variations and 
mistakes as possible. Search terms were refined to a point where at least 80% of cases 
returned by the search were true OA cases. This involved opening the cases returned by the 
search terms and identifying whether a diagnosis or strong evidence of OA was made either 
                                                             
4 See: http://www.venomcoding.org/VeNom/Welcome.html 
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during or before (and continued through) 2013 according to the case definition. A total of 18 
search terms were used in the final investigation. Search terms were also ran through the 
treatment notes using a variety of common OA treatments. These were again narrowed down 
to a smaller list to include those with highest sensitivity when searching through the EPRs for 
an OA diagnosis.  
The study questions to be included on confirmed OA cases were also tested at the pilot stage 
to determine whether they were answerable using the given information within the EPRs and 
any that were not suitable were dropped from the full investigation. Using the study 
questions, data was recorded from the EPRs pertaining to; when and how the diagnosis was 
made, signs of disease, treatments, behaviour and death or end of EPR notes. Additional 
questions were included to allow for owner non-compliance with vet advice: e.g. ‘was X 
recommended?’, followed by ‘was X implemented/prescribed?’ (Table 7: See appendix). 
Certain questions were reviewed for the 3 months either side of the diagnostic episode of care 
(see table 7), to identify occurrences of relevance to the onset of OA. Changes or occurrences 
reported outside of the 3-month window were considered to have a lower likelihood of 
association. 
Main Study 
At stage 1, searches were conducted on the database to identify OA cases within a sampling 
time frame 1 Jan 2013-31 Dec 2013. Search terms used included: Osteoa*, OA, Degen* + 
Joint*, Joint dise*, DJD, Osteoph*, Arth*, and for treatment notes: Cartrophen ~ 2, Seraquin, 
Hill JD,  Yumove, “Mobility treats”, Cosequin, Green lipped (mussel), ArthriAid, Adequan, 
Specific canine cjd, joint support, Chondroitin. Osteoarthritis cases were included if the EPR 
showed evidence that the dog met the case definition during 2013. Cases were also included 
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if the records showed continuation of treatment or insurance claims from a pre-existing 
diagnosis before 2013.  
An osteoarthritis case was defined as any dog with strong evidence for appendicular skeletal 
osteoarthritis recorded in the EPR (e.g. a final recorded diagnosis of or insurance claim for 
osteoarthritis (or synonym [see appendix])) or that was clinically managed for osteoarthritis 
e.g. rest, NSAIDs & supplements (or synonym [see appendix]) or where imaging findings 
were recorded that were indicative of OA (e.g. osteophytosis, enthesiopathy, new bone 
formation, subcondral sclerosis, Morgan’s line). 
Exclusion criteria as part of the case definition included: 
i. Dogs where osteoarthritis, DJD or synonym was only listed as one of a differential 
list.  
ii. Dogs with a diagnosis of osteoarthritis, DJD or synonym that was later revised to 
exclude osteoarthritis in the clinical notes. 
iii. Dogs diagnosed with immune mediated, auto-immune, rheumatoid and septic 
arthritis/polyarthritis  
iv. Dogs with a diagnosis of spinal conditions related to OA 
 
At stage 2, EPRs were coded within the VetCompass database as a case or non-case, based on 
the EPR containing evidence matching the case definition. Every third identified case then 
underwent further data extraction using a series of study questions related to the patient, 
diagnosis, treatments and behaviour (Table 7).  
At stage 3, relevant records were exported from the VetCompass database to a Microsoft 
Excel (2016) worksheet for data cleaning and analysis. Descriptive analysis was conducted 
within Excel for duration and behaviour observations. The prevalence estimate was 
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calculated from dogs that had OA during the study period (2013) either incident or pre-
existing cases. Due to the timeframe of this project, the prevalence had to account for 
subsampling which meant prevalence was calculated from a subsample of the candidate 
population (37%) which was then used to calculate the prevalence of OA in the overall 
population. Prevalence was also calculated for the most frequently diagnosed breeds (number 
of OA cases in breed X / total number of breed X in sample population).  
Three duration calculations were used to find an overall mean average figure for length of 
condition. Average duration was calculated using date of first diagnosis to date of final 
record, followed by date of first diagnosis to date of death (if occurred) and finally date of 
diagnosis to date of coding (for cases where death did not occur) as it was assumed it would 
still be currently present, even if managed. Percentage of life affected was then calculated 
using only individuals that died during the study period, using: duration (date of first 
diagnosis to death) / age at death.  
Severity Scale 
A severity scale was developed which combined a novel adaptation of the GISID severity 
scoring system (Asher et al., 2009 and Summers et al., 2010) and proxy measures related to 
OA, specifically designed for use with clinical data. Four areas of scoring included in the 
GISID score are prognosis, treatment, complications and behaviour. The areas scored from 
the sampled identified cases were adapted from the GISID, but had to incorporate suitable 
information available in the EPRs. The prognosis score was not applicable in the case of OA 
which is an incurable chronic disorder and therefore this was adapted to become signs of 
disease to reflect the level of pain an individual may be experiencing. The number of signs 
displayed by the dog such as limping, crepitus and stiffening could all be correlated with 
severity and the more signs shown the more severe the case is likely to be.  Treatment was 
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included within the severity score and included all medical, surgical and lifestyle therapies. A 
score was awarded based on the number of treatments given to an individual the more 
treatment options provided by the vet the greater the severity is likely to be. The 
complications element of the GISID was adapted to become quality of life compromisers, due 
to the lack of complications noted within the EPRs. Quality of life (QoL) compromisers, such 
as restricted exercise, or weight management could have an impact upon the health and 
welfare of the individual and therefore affect QoL. Finally, behaviour was also included 
within this scoring system. However, in this system it was based upon 8 behaviours listed at 
the initial stages of the study and a score being awarded based on the number of behaviours 
exhibited by an individual. Behaviours chosen included aggression, reluctance to exercise 
and others associated with pain-related conditions.  
A score was determined for each coded case based on point scale system (Signs and 
treatments both 1-6; QoL compromisers and behaviour both 1-4). (Fig 3). The minimum 
score obtainable was 0, whilst the maximum score obtainable was 20. 
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Statistical Analysis 
The data showed normality when tested and therefore parametric modelling was used 
throughout the statistical analysis. A fully factorial univariate general linear model (GLM) 
ANOVA was run on the 1259 fully coded case individuals to test for an association between 
breed size (as determined by the UK Kennel Club breed standards5) and group (e.g. hound, 
terrier working, pastoral, gundog, utility or toy), age at diagnosis, duration of OA, whether 
weight loss was recommended, and severity score. Following this a multivariate GLM was 
conducted to test for associations between breed size, group, weight loss and age at diagnosis 
(independent variables), and duration and severity score (dependent variables), using SPSS 
v22. 
                                                             
5 See: http://www.thekennelclub.org.uk/services/public/breed/ 
Figure 3: Scale used to calculate severity using four areas of measurements from the 
EPRs 
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An unmatched case-control risk analysis was conducted on all cases (4197) (both incident 
and pre-existing confirmed cases) and non-case controls (controls defined as all dogs in the 
denominator population excluding unconfirmed cases from the candidate case list), using a 
binary logistic regression model to test the associations of breed type, sex, age, insurance, and 
neuter status with the development of osteoarthritis. Univariable models were run for each 
risk initially and statistically significant variables were then put into a multivariable model.  
An automated backwards elimination (Wald) model was used in order to remove the least 
significant variables from the final model (using the probability of the Wald statistic). 
Pairwise interactions were included for all variables in the multiple model, to explore 
potential interactions between terms not previously investigated. Biological relevance was 
considered for interactions before putting them in to the model. Finally, within Excel, 
behaviour observations were counted, and type of management of OA cases was also 
counted. An automated backwards elimination (Wald) binary logistic regression analysis was 
conducted on the 1259 fully coded cases to highlight the effect of breed size, age, insurance 
status and number of body sites affected on whether or not a dog was radiographed as a 
diagnostic method. 
Results 
 
Study Population 
Overall, 455,557 dogs were included in the study as a denominator population, which had at 
least one EPR (not disease specific) either during 2013, or both before and after.  Following 
the initial input of relevant search terms, 16,437 candidate osteoarthritis cases were identified 
from the denominator population (Table 8). Of these, 6102 (37%) were manually checked 
and 4196 of these were confirmed as osteoarthritis cases. 1259 (of the 4196 cases) underwent 
full data extraction using the questions listed in Table 7. 
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Table 8: Table summarising the population characteristics of the denominator and 
candidate populations. 
Population Characteristic Denominator Population Candidate Population 
Number of individuals 455,55 7 16,437 
Average Age in 2013 (mean) 5.1 years 9.3 years 
Sex Male:                    234,212 
Female:                219,033 
Unknown:            2,312 
Male:                    8,698 
Female:                7,715 
Unknown:                 24 
Insurance Status Insured:                31,737 
Uninsured:           26,029 
Unknown:            397,791 
 
Insured:                2,981 
Uninsured:           1,225 
Unknown:          12,232 
Neuter Status Neutered:             205,020 
Entire:                  178,218 
Unknown:            72,319 
 
Neutered:              9,405 
Entire:                  3,266 
Unknown:            3,766 
Purebred Status Purebred:              340,769 
Crossbred:            98,931 
Unknown:             15,857 
Purebred:            12,579 
Crossbreed:          3,568 
Unknown:                290 
 
Prevalence 
The estimate of prevalence of OA diagnosis in dogs attending UK primary-care practices 
overall was 2.5% (95% confidence interval: 2.44-2.53). In total, 163 breeds were diagnosed 
with OA. Breed prevalence was calculated for frequent breeds in the sampled cases and then 
using the denominator population for the most frequent breeds, in order to account for breed 
popularity. Frequent breeds were defined as those that had 50 or more individuals included in 
the OA diagnosed population (Table 9).   
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Table 9: Number of cases in the most frequent breeds diagnosed with OA and the 
prevalence in sampled cases and overall 
Breed Number of 
OA cases 
Prevalence 
in sampled 
in cases 
(%) 
Number in 
overall 
denominator 
population 
Breed prevalence overall 
(accounting for breed 
popularity in 
denominator population) 
(%) 
Labrador 753 17.9 23324 3.24 
Staffordshire 
Bull terrier 
248 5.9 21192 1.17 
German 
Shepherd 
224 5.3 8542 2.61 
Border Collie 205 4.9 8584 2.39 
Golden 
retriever 
156 3.7 3807 4.10 
Jack Russel 122 2.9 57943 0.21 
West Highland 
Terrier 
113 2.7 8411 1.34 
Rottweiler 107 2.6 3724 2.87 
Cocker Spaniel 95 2.3 33236 0.29 
Cavalier King 
Charles  
91 2.2 7100 1.28 
Springer 
Spaniel 
70 1.7 4060 1.72 
Yorkshire 
Terrier 
70 1.7 10798 0.65 
English 
Springer 
67 1.6 3768 1.78 
Boxer 67 1.6 4398 1.52 
 
Duration  
Average age at diagnosis of OA was 8.6 years (±3.6 years SD) (average age of dog 
population in 2013 was 5.1 years (± 4.0 years SD) (Fig 4), with age of diagnosis ranging from 
0 to 19 years. The average duration was 2 years (±1.7yrs SD), however it ranged from 0-11 
years.  The average percentage of life affected by OA was calculated at 11%. 
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Figure 4: a) Histogram showing age at diagnosis b) Histogram showing age of 
denominator population during 2013 
a) 
b) 
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Severity 
The average severity score for the sample of 1261 cases was 6.0 (±2.3 SD) with a range of 0-
13 (out of a maximum 20).  In the univariate model (dependent variable= severity), whether a 
dog was recommended to undergo weight loss had a significant association with severity 
score (Univariate ANOVA: F=16.4, p<0.001, df=1), with overweight individuals (weight loss 
recommended) having higher severity scores. Duration of disease also significantly affected 
the severity score (Univariate ANOVA: F= 5.6, p=0.018, df=1).  Breed size, breed group and 
age at diagnosis, had no significant effect on severity score (Table 10). In the multivariate 
model (dependent variables = severity and duration) that tested for associations between 
breed size, breed group, age at diagnosis and whether weight loss was recommended, only 
whether weight loss was recommended was significantly associated with severity score 
(General Linear Model: F=15.4 p<0.001, df=1) (Table 11). During the period of study, 410 
dogs died, of which OA contributed to the euthanasia of 264 dogs (64%)..  
Table 10: Results of Univariate ANOVA for association of variables on severity 
Independent Variable Dependent Variable df F Significance 
Age at diagnosis Severity 1 .013 .909 
Breed Size Severity 2 1.580 .287 
Breed Group Severity 8 .8.25 .581 
Weight Loss recommended Severity 1 16.407 .000 
Duration  Severity 1 5.607 .018 
     
 
Table 11: Results of multivariate general linear model for association of variables on 
severity score and duration 
Independent variable Dependent Variable df F Significance 
Age at diagnosis Severity Score 1 .000 .991 
Duration 1 2.149 .143 
Breed Size Severity Score 2 1.515 .221 
Duration 2 .300 .741 
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Risk Analysis  
In the univariable binary logistic regression all variables (insurance status, age, sex, neuter 
status and breed group) were significantly associated with a diagnosis of OA (<0.10) (Table 
12) and were subsequently included in the multivariable binary logistic regression. The 
multivariable model showed that insurance status (Binary Logistic Regression: Wald=51.9, 
p<0.001, df=1), and age (Binary Logistic Regression: Wald=381.1, p<0.001, df=1) were both 
significantly associated with an OA diagnosis where insured individuals were 2.2 times (OR 
95% CI 1.8 to 2.7) more likely to have a diagnosis of OA than non-insured individuals. The 
breed groups that had statistically significantly decreased odds of a diagnosis of OA when 
compared with crossbreeds were: Gundogs, pastoral, toy, utility and working breed groups 
(Table 13). Sex and neuter status were insignificant in the risk analysis and therefore 
eliminated in the final model (Table 14). The final model had R2 (Cox and Snell) of 0.027.  
Table 12: Results of univariable binary logistic regressions for analysis of risks 
contributing to an OA diagnosis 
Independent 
Variable 
Dependent 
Variable 
df Wald Significance 
Age at diagnosis OA Diagnosis 1 5892.059 .000 
Insurance status OA Diagnosis 1 91.606 .000 
Breed Group OA Diagnosis 7 1040.548 .000 
Neuter status OA Diagnosis 1 633.959 .000 
Sex OA Diagnosis 1 9.075 .003 
     
 
 
 
Breed Group Severity Score 8 .801 .601 
Duration 8 1.248 .268 
Weight loss recommended Severity Score 1 15.401 .000 
Duration 1 1.954 .163 
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Table 13: Results of binary logistic regression for association of breed group on having 
a diagnosis of OA compared to crossbreeds 
Independent Variable Dependent Variable df Wald Significance Odds Ratio 
Gundog OA Diagnosis 1 14.982 .000 .420 
Hound OA Diagnosis 1 .094 .759 .936 
Pastoral OA Diagnosis 1 13.728 .000 .220 
Terrier OA Diagnosis 1 .018 .893 .968 
Toy OA Diagnosis 1 15.722 .000 .367 
Utility  OA Diagnosis 1 24.092 .000 .232 
Working OA Diagnosis 1 16.572 .000 .292 
 
 
Table 14: Results of binary logistic regression for association between neuter status and 
sex and having a diagnosis of OA 
Independent 
Variable 
Dependent 
Variable 
df Wald Significance 
Neuter status OA Diagnosis 1 .142 .707 
Sex OA Diagnosis 1 .763 .382 
 
Behaviour 
Two hundred and fifty (19.9%) of the dogs with full data extraction had 1 or more 
behavioural issues reported in the EPR within ± 3 months of the OA diagnosis, with 342 
separate behavioural issues noted. The most common behavioural issues included: (i) the dog 
is quieter (defined as lethargic, lack of appetite/thirst, not well in self less vocal and sleeping 
more) (24% of reported issues); (ii) alteration in normal behaviour (excessive 
licking/chewing, panting, clingier, soiling in the house) (24% of reported issues); (iii) 
reluctance to exercise (19% of reported issues); (iv) aggression (11% of reported issues); and 
(v) increase in vocalisations (defined as yelping, whining, barking) (9% of reported issues) 
(Fig 5) 
.  
 
54 
 
 
  
 
 
 
 
 
 
 
 
 
Diagnosis and Clinical Management 
A binary logistic regression test for independent variables (breed size, age, number of sites 
affected by OA and insurance status) affecting whether a case was radiographed or not was 
conducted. The model showed that breed size and number of sites affected had no effect on 
whether the individual was radiographed and were subsequently eliminated from the final 
model. Insurance status was statistically significantly associated with whether a dog was 
radiographed (Binary Logistic Regression: Wald=4.160, p=0.04, df=1) where insured 
individuals were 2.4 times (OR 95% CI 1.2 to 6.4) more likely to be radiographed than non-
insured individuals. Age was also statistically significantly associated with whether a dog 
Figure 5: Chart showing the percentage of behaviours exhibited by dogs recorded in 
the EPRs ± 3 months of OA diagnosis 
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was radiographed (Binary Logistic Regression: Wald=16.613, p<0.001, df=2), with the 
model showing young and adult dogs were less likely to be radiographed.  
 
Eighty-eight percent of OA cases were managed with at least one treatment (i.e. medical or 
surgical treatments, excluded behavioural treatment) following the diagnosis of OA.  78% 
were treated using an analgesic drug, with NSAIDs being the most frequently used. 4.8% of 
cases were treated surgically (of these 4.8%, 79% were also treated with an analgesic), and 
4.6% were referred for further investigation and/or treatments (of these 4.6%, 85% were also 
treated using an analgesic).  
Discussion  
 
Prevalence estimates for osteoarthritis (OA) have ranged from 6.6% (O’Neill et al., 2014) to 
20% (Johnston, 1997) and therefore there is a need for reliable and large scale prevalence 
data, in order to identify the impact of OA on canine welfare. In this study, prevalence was 
calculated at 2.5% from a sample population of 455,557 dogs attending primary care 
practices. The prevalence estimate of 2.5% is significantly lower than the previous estimates 
(O’Neill et al., 2014 and Pettitt and German, 2015). This is likely due to differences in 
methodologies (such as data type and sample sizes) and research populations (such as 
primary-care patients versus referral patients). However, the use of primary care data has 
been suggested to be more representative of the general dog population (O’Neill et al., 2016). 
It should be noted however, that due to the case definition designed to increase the specificity 
of the study, the prevalence estimate is likely to be slightly less than the true population 
prevalence rate, as cases that were likely to be OA had to be discarded due to lack of 
sufficient information provided in the EPR. The time frame of this study meant prevalence 
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had to account for subsampling and therefore there may be some variation with this figure 
estimate. 
Additionally, the methodology of this current study using primary care data heavily relies on 
the input from the veterinarian treating the individual. As one vet’s hip dysplasia may be 
another’s OA due to differing examination and diagnostic procedures, there is likely some 
variation around the 2.5% estimate. Recent studies have shown significant variation between 
what is discussed in preventative medicine consultations such as annual booster 
appointments, versus specific health problem consultations. Preventative medicine consults 
provide a platform for the vet to detect other health problems such as OA that may be 
unnoticed by the owner, and therefore health discussions initiated by either the vet or the 
owner should be encouraged in these cases. However, this again relies on the veterinarian 
recording this in the EPRs (Robinson et al., 2016).  A study examining the amount of the 
consultation that ends up recorded in the EPRs found that 64.4% of problems discussed 
during the consultations and 58.3% of actions undertaken were recorded in the EPR.  Other 
variables that affected whether something was recorded within the EPRs included who raised 
the problem (i.e. owner or vet) and at what point it was raised during the consultation, and 
what action was taken. Ultimately it is the vet who decides what are the most important 
aspects of the consultation and what gets recorded in the EPR This therefore highlights some 
limitation to use of primary-care EPR data and demonstrates that some cases may be missed, 
or have reduced information due to lack of recording of data from consultations (Jones-Diette 
et al.). Many OA cases may also not have been included due to lack of follow up, or as OA 
was listed as one of a list of differential diagnoses. Also, cases progressing from previous 
conditions such as hip dysplasia or cruciate ligament rupture may not have been followed up 
in the notes as OA and therefore were discarded due to the specificity of the case definition 
57 
 
applied. However, irrespective, this estimate still equates to thousands of individuals affected 
by OA and therefore the problem still needs addressing. 
The breeds with the highest prevalence are all breeds that have previously been associated 
with both predisposing conditions and OA. Additionally, there is the suggestion that larger 
breeds are more prone to developing OA, due to increased load on their joints (Grierson et 
al., 2011 and Lavrijsen et al., 2014b). Therefore, the finding of frequent diagnosis in West 
Highland White Terriers and Cavalier King Charles Spaniels was interesting, as these are 
breeds that have not been frequently discussed as susceptible breeds for OA, however they 
have been suggested to be prone to patellar luxation (Bound et al., 2009). On another note, 
recent studies suggest obesity could affect up to 40% of dogs, and therefore this could explain 
why OA is being seen more in all types of breeds (Handl and Iben, 2012).  
The mean age of diagnosis was 8.6 years, and the median age 9 years, showing diagnosis is 
often made in older individuals (Fig 4a). The age at diagnosis was quite old in comparison 
the overall population with the mean age as of 2013 when the EPRs were checked for OA, 
being 5.1years (±4.0 years SD) (Fig 4b). Therefore, either this is occurring more in older 
dogs and the associated degeneration the condition presents with is strongly correlated with 
age or it is only noticed later in life. The difficulty with OA as a disease is that it can present 
at any life stage, both during growth and in both adult and older dogs. In addition, OA can 
present differently symptomatically and on imaging and therefore may not necessarily be 
picked up by the owner or vet until it has developed to a certain level (Pettitt and German, 
2015).   
The range (19 years) for age at diagnosis showed that the minimum age of diagnosis was 0 
years old. This shows that as OA can occur from a very young age and it can have long 
duration if these animals then live a long life. Many cases may well be diagnosed later in life, 
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but earlier signs may be missed and may only become apparent when the animal ages and 
therefore many more dogs could be suffering for a longer duration, with implications for 
welfare. In this study, the mean duration was 2 years, with calculations showing percentage 
of life affected as 11%. A study trialling OA treatment found an average duration of OA 
before starting the trial of 2.2 years demonstrating a similar figure to this study (Reymond et 
al., 2012).  
Duration could be considered as a measurement of severity, the longer the duration the more 
severe the disorder is likely to be as there is increased time to suffer and progress. This study 
attempted to quantify severity based on proportion of life that is affected by what can be 
debilitating pain. Whilst other treatment studies acknowledge that OA has the potential for 
long term impact on health, there is very little information available on duration of OA itself.  
The severity scale used was adapted from the current GISID scoring system (Asher et al., 
2009) and proxy measures for severity, based upon the information provided about OA in the 
EPRs (Fig 3). This scale incorporated two measurements of severity from the dog and two 
from the perspective of the owner/vet in order to produce a score which is as valid as 
possible. The mean average score was 6, with a range of 0-13 (out of 20). Referring back to 
the GISID the range in this study would be equivalent to around 0- 11 on the GISID scale 
(based on differences between the maximum scores between these scales). Previous ranges 
found for similar conformational disorders include patellar luxation which had a range of 6-9, 
showing that on an individual basis, OA can be considered more severe. Other conditions that 
are frequent concerns to canine welfare that affect breathing and brain function include 
brachycephalic airway obstruction syndrome, (range 6-15), cranioschisis and syringomyelia 
(both 13-15). These are considered to be severe conditions with serious welfare impacts, and 
from this study the highest severity of score awarded for OA was within these ranges. 
59 
 
However, these scores are not directly comparable, and therefore severity scores between 
groups were calculated to identify if there are any differences in severity with certain 
variables. 
Whether or not weight loss was recommended was a statistically significant factor in both the 
models, with dogs recommended to lose weight receiving higher severity scores. Dogs that 
are recommended to lose weight can be assumed to be overweight, therefore suggesting 
severity is correlated to excessive weight / obesity and therefore is highly important in OA 
management. Obesity is already well discussed as a risk factor for developing OA (Kealy et 
al., 1997, Kealy et al., 2000, Runge et al., 2010 and Smith et al., 2001) and this study 
suggests that it also contributes to the severity of the disease itself once developed. This is 
important to consider when managing OA, and any dogs that are overweight at diagnosis 
must have this brought to the attention of owners in order to alleviate some of the severity of 
OA for that individual. Breed size and breed group had no impact on severity. Age at 
diagnosis had no impact on severity score, however duration was significant for OA severity, 
suggesting that with progression of OA severity increases which is to be expected. Of the 
dogs reviewed in full, OA was a contributing factor in 64% of dogs euthanased.  This is a 
high proportion and demonstrates that OA frequently contributed to death underlining its 
importance in   veterinary medicine and dog welfare.  
Insurance status was a significant ‘risk factor’ associated with whether a dog was diagnosed 
with OA, where insured individuals were 2.2 times more likely to have a diagnosis of OA 
than non-insured individuals. This has also been found in other studies relating to other 
diseases (Taylor-Brown et al., 2015). In the case of OA, it is likely that this finding is due to 
the need for specialist diagnostic images for diagnosis confirmation as well as the long-term 
nature of the condition and therefore treatment and costs. It may be the case that uninsured 
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individuals did not receive a firm diagnosis (i.e. the diagnosis was part of a differential 
diagnosis) and/or no follow up diagnosis in the EPRs due to the owner not bringing their dog 
back in, meaning they are excluded as cases from the study according to the inclusion 
criteria.  
It is frequently mentioned that crossbreeds are healthier and less predisposed to developing 
diseases, particularly inherited disorders (Bellumori et al., 2013), however our results suggest 
that five breed groups (gundogs, pastoral, toy, utility and working breed groups) had 
significantly decreased odds of developing OA compared to cross breeds. This suggests there 
may be improvements in breeding practices or could be due to the fact that these breed 
groups may be prone to developing a variety of inherited disorders in comparison to 
crossbreeds and therefore OA may be overlooked in some of these cases where more severe 
disorders prevail. This again should be used and taken into account when choosing breeds 
and individuals to breed from. 
Previous research has suggested that males have greater odds of developing OA than females 
(Hays et al., 2007) and that neutered individuals have higher odds of developing cruciate 
ligament problems and hip and elbow dysplasia (Adams et al., 2011, Taylor-Brown et al., 
2015 and Witsberger et al., 2008). It was also highlighted in the meta-analysis in chapter 2, 
that males have greater odds of developing OA. In the current study, sex and neuter status 
were not statistically significant in the risk analysis. The study in this chapter used much 
larger datasets than many of the previous studies and the meta-analysis, as well as using 
primary-care data and therefore may account for the differences in results. Further studies on 
the effect of sex and neutering on development of OA would be beneficial. 
The results from the current study highlight that age of diagnosis is most frequently dogs 
aged 8 years and over, supporting the studies that suggest it is more common in older dogs 
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(Runge et al., 2010). Many cases in younger individuals are likely developed from hip or 
elbow dysplasia and cruciate ligament rupture which have been shown to occur in younger 
individuals (Grierson et al., 2011, Inauen et al 2009 and Witsberger et al.,2008). In the case 
of this study, cases were only recorded at the point they were diagnosed firmly as OA and 
therefore could have occurred in much younger dogs from these conditions, but not noted as 
OA until much later on. 
It has previously been reported that there is a lack of attention to behaviour within primary-
care consultations and that the physical conditions are addressed more frequently than 
psychological complaints (Roshier and McBride, 2012a&b). One of the aims of this study 
was to investigate this further, and to identify behavioural issues that are commonly reported 
alongside OA.  19.6% of OA cases presented with at least one behavioural problem or change 
recorded with the EPR. This showed that behaviour was discussed in nearly a fifth of primary 
care consultations which, if followed up, may allow for better treatment of behavioural 
changes associated with pain-causing conditions. However, whilst this is a good 
improvement with respect to the amount of behavioural discussion in primary care (when 
compared to the studies previously mentioned), OA cases with behavioural complaints could 
be much higher than 19.6%, but not addressed in the EPRs. In addition, there is still a need 
for vets to diagnose behavioural changes and refer to behaviourists if appropriate, for 
treatment of these issues as this can otherwise contribute to decisions to euthanize.  The most 
frequent behavioural complaints found to be associated with OA in this study included: 
quieter (defined as less vocal, lethargic, lack of appetite/thirst, not well in self and sleeping 
more), alteration in normal behaviour (e.g. clingier, excessive licking/chewing, panting, 
soiling in the house), reluctance to exercise, aggression and increase in vocalisations (defined 
as yelping, whining, barking) (Fig 5). This highlights the need to discuss behaviour within 
consultations when an individual appears to be presenting with pain, so that owners are more 
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likely to recognise pain-causing behaviours, and thus seek appropriate treatments. Also, 
making owners aware of the link between behaviour change and pain can enable them to 
notice subtle changes and bring their concerns to their vet earlier and thus allow for earlier 
diagnosis of OA. 
In relation to clinical management of OA, 90% of cases were managed with at least one 
treatment following diagnosis, 80% of which included the use of an analgesic drug. 4.8% of 
cases were treated surgically, as well as 4.6%% being referred for further investigation and/or 
treatments. The low surgical intervention may be due to the risks relating to the surgery or the 
resulting implications on quality of life that can occur during rehabilitation and recovery. It 
could also suggest that veterinarians believe appropriate care can be administered without this 
type of intervention. Surgical intervention is usually seen as only necessary in the case of 
severe OA when other managements have been ineffective (Pettitt and German, 2015), as 
surgery results in further pain again, complications/risks and restricted exercise. The low 
referral rate could suggest that primary care clinicians believe that OA can be diagnosed and 
managed suitably in the primary care setting without the need for referral. Eighty percent of 
cases in this study were managed using an analgesic treatment, prescribed at the primary care 
consultations, the majority of these (97%) were NSAIDs. Whilst continual, long term use of 
NSAIDs has been suggested to sufficiently alleviate pain associated with OA, long duration 
of use can lead to complications and have an impact on quality of life through the 
development of organ problems, such as kidney or liver problems (Innes et al., 2010). In this 
study, 75% of cases were on treatment at the end of the record. This also highlighted that 
20% of individuals were not treated using an analgesic treatment; this may be for a variety of 
reasons including the owner believing that their dog is not in pain. This indicates that there is 
a clear problem with vets convincing owners that their dogs are in pain when they present 
with signs such as limping and thus are in need of analgesia. This is a serious concern with 
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respect to animal welfare with many dogs unnecessarily suffering from potentially 
debilitating pain. This needs emphasising both in veterinary medicine and to owners in order 
to increase the awareness of signs of pain in dogs.    
Exercise restriction was recommended in 21% of OA cases. It has been shown that 
osteoarthritis can significantly affect the gait of a dog, which in turn can impact unaffected 
joints and can therefore increase the severity of the disease for that individual. Exercise 
restriction is therefore important in order to prevent further damage to other joints until the 
pain associated can be managed for example by dietary management or by analgesic methods 
(Bockstahler et al., 2012).  Exercise is recommended to be restricted but not stopped all 
together as this can be detrimental to the health of the dog (Petitt and German, 2015). For an 
active species however, exercise can be extremely important both physically and mentally 
(Taylor and Mills, 2007), so this finding suggests canine welfare sometimes is affected 
through treatment in the short term (e.g. where OA affects the biological need for exercise 
and activity as part of behaviour) in order to improve the welfare in the long term. Therefore, 
it could be suggested that restriction should only be recommended with severe disease, and 
the benefit of interventions to assist dogs to cope psychologically with restriction should be 
considered. 
Twenty-eight percent of cases were recommended to undergo weight loss. This supports a 
correlation to being overweight and obesity on the development of OA. However, it could 
also suggest cases diagnosed with OA gain weight, perhaps through reduced exercise. This 
link therefore requires further investigation. Reducing food intake may again reduce the 
quality of life in the dog, a species that is well known for being food motivated. It has been 
shown in previous studies that diet alterations and food restrictions can have an effect on the 
behaviour and wellbeing of dogs (Bosch et al., 2007 and Crowell-Davis et al., 1995). This 
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demonstrates further that the management of OA can have a large impact on canine welfare 
and specific interventions must be carefully considered to ensure that they outweigh the 
implications of not implementing them.  
At the start of the study it was acknowledged that radiographs may be required to provide a 
firm diagnosis of OA, however they do have their limitations (Pettitt and German, 2015). 
However, it was noted that many OA cases would not be accounted for if a radiograph had to 
be done to include them as a case. In some cases, radiographs were strongly recommended by 
the vet but rejected by the owner. Therefore, the case definition was expanded to allow for 
non-radiographed individuals to be included provided they meet other requirements of the 
case definition as these can’t be discarded without potentially significantly under-estimating 
prevalence. A variety of reasons noted in the EPRs for not using radiography included lack of 
insurance or dogs age/other illnesses, and therefore a regression analysis was conducted to 
test for differences in insurance data, age, how many body sites were presenting with OA and 
breed type, in order to identify whether there were significant reasons for radiographing or 
not so as to acknowledge and understand why it may not be used as much.  
Insurance status was a significant variable, where insured individuals were significantly more 
likely to be radiographed than non-insured individuals. This is no surprise as the cost of 
radiography was a clearly noted reason within the EPRs for not radiographing, and those with 
insurance are much more likely to be able to pay for radiographic diagnoses. This shows that 
a large proportion of uninsured individuals may suffer as a result of unaffordable treatment 
which is a concern for animal welfare. Age was a significant factor in whether a dog was 
radiographed, with the model showing young and adult dogs were less likely to be 
radiographed. This showed that older dogs were more likely to be radiographed despite the 
risks of anaesthetic and recovery being higher in older dogs. This study also showed that 
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duration affects severity and therefore older individuals may appear to present with more 
severe OA and thus be recommended for radiographs by the vet. This also supports that cases 
can’t be discarded because they weren’t radiographed as this would significantly 
underestimate the actual number of OA cases in further studies. 
Whilst there is large potential in the analysis of large datasets such as this to better understand 
the welfare impact of a condition, there are a number of limitations. Firstly, only dogs that 
presented for consultations at veterinary practices were included in this study and 
consequently the results obtained could potentially not represent the entire population and for 
those that are not registered with a veterinary practice. Similar to this, animals registered with 
a vet and insured animals are a biased sample, as these owners are likely more invested in 
their animal than those that don’t.  This may result in a lower prevalence estimates as many 
other animals may have the condition but are not taken to the vet for diagnosis and 
management. Secondly, the data is only as good as the notes recorded during short 
consultations by the vet, as well as the level of information that is provided by the owner. 
This study relied on the vet to make diagnoses of OA, as well as record adequate data in the 
EPRs surrounding all aspects around the diagnosis. Therefore, there are possibilities that 
some dogs with OA were not diagnosed at all or that some recorded were also misdiagnosed. 
The denominator population include all dogs that attended a practice in 2013, whether 
presenting healthy (for preventative medicine consults) or sick (but not disease specific). 
Therefore, it may well be the case that undiagnosed cases exist in the denominator population 
too, or lack of data in the EPR meant they were not highlighted as candidate OA cases in this 
study. Again, in particular this could affect the reliability of the risk factor analysis. However, 
it should be noted, in the case of the risk analysis, unchecked candidate cases were removed 
from the denominator population.  
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The time frame of this study meant the methodology for calculating prevalence had to be 
account for subsampling, with only 37% of cases coded (as case or non-case) and therefore 
there may some variation with the overall figure estimate that was calculated for the 
population. 
 
Finally, the severity score used in this study is again restricted to the information provided by 
the note taker on treatments and management or detail the owner at provides of any 
behavioural changes and signs. As this is, this study represents a pilot severity study using an 
OA specific scale. The current scores are stand-alone figures and not directly comparable to 
others. Further work in this area is recommended, to expand the current scale to be applicable 
to a range of primary-care disorders.  
Conclusion 
 
This study found a prevalence estimate of 2.5% for OA in the UK dog population. Based on 
UK dog population estimates this equates to just over 200,000 individuals. It was also shown 
that diagnosis occurred in older individuals. This study supports that older dogs are diagnosed 
more frequently than younger dogs, however dogs as young as 1 year of age were diagnosed 
with OA during this study. The average severity score for OA in this study was 6/20, and 
both age and obesity were found to be significantly associated with severity. The average 
duration of OA was 2.2 years affecting 11% of life, suggesting OA poses a great threat to 
canine welfare and needs addressing in more depth in veterinary medicine.  
Risk factors identified by this study include age, breed group and insurance status. Clinical 
management of OA was implemented in 90% of cases with use of analgesics being the most 
frequently used form of management. This is the first study known to look into behaviour 
reporting in primary care EPR and behaviours specifically related to OA.  It was shown that 
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19.6% of OA cases presented with a behavioural complaint, also highlighting behaviours 
associated with OA, which suggests behaviour discussions are increasing in the primary care 
setting, but there is still room for this to improve. This highlights the need to discuss any 
behavioural complaints as well as physical signs as many pain related behaviours associated 
with OA were identified during this study.  
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Chapter 4 
Discussion 
Osteoarthritis (OA) is a major health problem in dogs which warrants investigative 
epidemiological studies in order to improve canine health and welfare. Whilst OA has always 
been associated with ageing, (due to inevitable joint wear and degradation), it has become 
evident that OA can occur earlier in life in many cases and therefore has serious implications 
for dog welfare (Kealy et al., 1997). As a chronic and progressive disease, it is important to 
understand the aetiology and the risk factors that contribute to its development (Runge et al., 
2008). Along with the aetiology and risk factors, it is important to calculate the prevalence, 
severity and duration of the disease in order to determine the overall welfare impact of the 
condition both at the individual and population level. This is therefore the basis of this 
epidemiological investigation, which set out to investigate epidemiological data on 
prevalence, severity, duration and risk factors, as well as highlight pain-related behaviours 
associated with OA and the level of behavioural discussion within primary care consultations. 
Risk Factors for Osteoarthritis and Predisposing Arthropathies 
The initial aim was to conduct a systematic review on an epidemiological measure that has 
substantial literature, but remains largely unanswered. The gaps lay within risk factors and 
aetiology of OA, where previous literature did not provide the full picture. The current 
literature surrounding risk factors that contribute to developing OA, is sparse and often only 
features a single factor as the topic of discussion. Therefore, a comprehensive review of all 
current risks listed in the literature was chosen as the topic for review in this study- 
hypothesising that OA development is a result of a combination of factors. This was then 
broadened to include predisposing conditions, which could be considered risk factors. Many 
cases of OA develop from existing arthropathies, and also have risk factors. Four clear areas 
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of risks became evident from the literature search: genetics, environment and lifestyle 
(inclusive of signalment), physiology and conformation. To support the review element, a 
meta-analysis across the published literature was performed, to estimate the strength of 
evidence for an association between potential risk factors and OA.   
The second study reported in this thesis was an epidemiological investigation into OA, which 
was conducted in collaboration with the VetCompass team at the Royal Veterinary College, 
London. The VetCompass project collects primary-care data from small animal veterinary 
practices around the UK. This dataset therefore provides an excellent source of information 
about a wide range of diseases affecting companion animal species in the UK, including 
canine OA. The aim of this study was (i) to estimate the prevalence of OA, (ii) to create a 
method of measuring severity of OA and to estimate the severity (iii) estimate the duration of 
OA. Risk analysis was also performed to support the previous literature review. Analysis was 
also conducted to identify key pain-related behaviours that are associated with OA, in order 
to provide education to allow for treatment of both physical and psychological elements, in 
pain-causing conditions. Prior literature has suggested that during primary care consultations 
behaviour is not discussed enough as consultations largely aim to provide relief for physical 
problems only (Roshier and McBride et al., 2013a&b). Therefore, this study also aimed to 
identify the frequency of discussions regarding behaviour within primary care settings.   
Risk factors for the development of OA were highlighted in both the systematic review in 
chapter 1 and risk analysis during chapter 2. The key risks associated with developing OA 
highlighted by published literature suggested that joint laxity is the most common risk factor 
directly associated with OA development (Smith et al., 2001). When associated with hip OA, 
a key risk relates to the Norberg angle of the hip with the lower the angle the greater the risk 
of developing OA. A strong correlation to obesity and development of OA has been 
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suggested in the published literature due to higher weight results in more stress on joint, a 
finding that is common amongst other species. Whilst OA can be strongly correlated to 
obesity, non-weight bearing joints also develop OA as a result of other joint factors such as 
laxity and Norberg angle (Kealy et al., 1997). 
Neutering is frequently mentioned as a risk factor and it is suggested that neutered individuals 
are at greatest risk of developing OA as a result of loss of gonadal protection hormones (Hart 
et al., 2014) and that males are more likely to develop OA.  This was not borne out by the 
study reported in Chapter 3, see later.  
Over exercising has been also shown as a risk due to the impact on the joints during 
developmental stages. Therefore, litters born in different seasons have demonstrated 
differences in susceptibility to developing OA. Litters born around autumn months were 
consistently shown to be less at risk of developing OA, likely due to reduced exercise levels 
outdoors during vital development ages (Worth et al., 2011).  
Regarding predisposing arthropathies, large and giant breeds are strongly associated with 
developing conditions likely to predispose to OA, in particular cruciate ligament rupture. This 
is again likely due to extra stress on joints due to body size, similarly to OA where obesity is 
suggested as a risk factor (Adams et al., 2011). Genetics has also been implied as a main 
factor for development of OA (Necas et al., 2000). Congenital defects such as hip dysplasia 
frequently develop into OA and is said to do so as a result of both genetics and environmental 
stressors (Runge et al., 2010), as is patellar luxation (Bound et al., 2009). 
The main findings in the literature suggest that OA is most strongly associated with genetics 
and obesity. For many of the predisposing arthopathies these are also considered risk factors, 
and therefore these should perhaps be the main targets in current practice to reduce cases of 
OA developing.  
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Genetics should be considered especially by breeders when selecting individuals to breed 
from and whilst many breeders likely do this, there are also likely many that do not. Given 
the finding in Study 2 that crossbreeds may be at higher risk for the development of OA, 
these considerations need to be taken beyond the pure breed breeders. Any individual or 
direct relative of an individual who has OA should not be bred from along with individuals 
with poor hip/elbow scores and joint laxity (Grondalen and Lingaas, 1991). Owners should 
also do appropriate research when sourcing a dog and should request health certificates for 
the dog where possible.  
Studies show that osteophytes, biomarkers and cytokines can be used as predictors and 
prevention tools, as they are present as early signs OA (Andrysíková et al., 2012; Hegemann 
et al., 2002, Maccoux et al., 2007 and Mayhew et al., 2002). This should be further explored 
to better assist breeders in decision making before selecting breeding stock. 
It can be concluded from the literature that OA is largely genetic disorder that is exacerbated 
through other stressors. Prospective cohort studies identifying the proportion of OA cases that 
develop from a particular risk factor, as well as determining the number of cases of OA that 
develop from other arthropathies would be beneficial to this area of study to further support 
the conclusions in this study and highlight any other particular risks.  
The unmatched case-control risk analysis conducted during study 2, showed that insurance 
status and age were both significantly associated with the diagnosis of OA. Diagnosis of OA 
was shown to be in older dogs and therefore this study supports other studies suggesting that 
OA occurs more in older dogs (Smith et al., 2001). This is likely due to a combination of age 
related degeneration of joints and tissues, as well increased exposure to other stressors such 
as exercise, diet and injuries compared to younger dogs. However as previously mentioned 
this could also be a result of numerous things, such as the dog’s ability to mask pain in the 
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earlier stages and only show signs when the disease progresses (Mathews et al., 2014), or the 
inability of the owner to recognise the dog is in pain and take it to the vet to obtain a 
diagnosis.   
Often crossbreeds are thought to have hybrid vigour compared to their purebred parents as a 
result of reduced homozygosity. However, it was shown in this study that crossbreeds have 
an increased chance of developing OA, compared to certain purebred breed groups. This may 
also be due to the fact that the individuals that are bred are not checked and screened the 
same way purebred dogs are, for example the Kennel Club hip scoring program. This could 
result in those that aren’t suitable for purebred registration to then be used in breeding 
crossbreeds, and thus resulting in poor genetics in the offspring, which end up increasing 
their susceptibility to disorders such as OA, instead of creating the desired hybrid vigour that 
crossbreeding sets out to achieve (O’Neill et al., 2013).  This highlights again the need for 
screening individuals for all breeding purposes whether it be for purebreds or crossbreeds, 
particularly when using animals genetically prone to OA. There were 5 breed groups that had 
decreased odds when compared with crossbreeds for developing OA. This could suggest that 
any individual is susceptible and supports the fact although crossbreeds have been frequently 
considered ‘healthier’ than purebreds (Bellumori et al., 2013), this needs to be reconsidered 
in light of this study’s findings and additionally the importance of environmental factors 
cannot be overlooked. A final possible explanation for this study’s findings is that purebred 
dogs may have a number of inherited disorders where OA is overlooked by a more serious 
but simultaneous condition (Asher et al., 2009), whilst crossbreeds may develop just a single 
disorder such as OA, and therefore be more noticeable and thus diagnosed more in this case. 
Further investigations are required to determine the underlying causes for these observed 
differences and to determine the most appropriate explanation of this finding. 
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Whilst many studies suggest sex and neuter status as risk factors, in the risk analysis model in 
this study these variables were insignificant. Previous studies have used much smaller 
datasets than the one used in this study, which is likely to give a much better representation of 
the whole UK dog population. However, regarding neuter status, due to the nature of the 
methodology using primary-care data, the neuter status of the individual was its status at end 
of record rather than at the time of diagnosis of OA, and therefore could explain the 
difference in significance in this study compared to previous studies. It was hypothesised that 
insurance status, age, sex, neuter status, purebred status and breed group are risks factors that 
increase the likelihood of an OA diagnosis, which was partly accepted as insurance status, 
age, purebred status and breed group were all significantly associated with OA diagnosis, 
however sex and neuter status were not found to be significantly associated. 
Osteoarthritis Prevalence 
It was hypothesised that prevalence of OA would be between 6 and 20% in the UK dog 
population. A prevalence estimate calculated in this study was 2.5% showing that whilst 
many individuals suffer from OA, the hypothesis is rejected as this is much lower than 
previous estimates. Whilst this still equates to thousands of affected individuals, it should be 
taken into account that this is a conservative estimate and therefore the scale of the problem 
could be much greater.  Even at the lowest estimate of 2.5% prevalence, OA is still of major 
concern- particularly in the case of the 20% that are not treated with analgesics, which is a 
major threat to canine welfare. There is very little prevalence data within published literature 
and there are many inconsistencies between estimates that do exist. O’Neill et al., (2014) 
calculated a prevalence estimate of 6.6% for OA. However, whilst this study similarly used 
primary care data, this was a broad study aiming to identify the top most frequently 
diagnosed disorders. This study differed from the current study in that no specific search 
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terms or case definitions were applied for accuracy of case versus non-cases differentiation. 
Instead an extraction of diagnosis term was made from EPRs, which could have led to an 
overestimate on prevalence, as it looked for the most frequently recorded conditions in 
practice without exclusion criteria for non-cases. However, what this study does show is that 
OA is an important disorder as it is included within the most frequently diagnosed disorders 
in veterinary practices.  
Prevalence estimates were also made for popular breeds and in both the current study and 
O’Neill et al., (2014), popular breeds with the highest prevalence included Labrador 
retrievers, German Shepherds and Staffordshire bull terriers. O’Neill et al., (2014) also found 
that Border Collie and Jack Russell terriers were popular breeds with high prevalence, 
however in this current study, although they were found to be popular breeds, OA prevalence 
was not as high as previous estimates.  As noted previously, this difference is likely due to 
the lack of specificity of the search terms and case definitions used in the earlier study, as it 
was conducted as a broad study to identify the most frequently diagnosed disorders, and 
therefore these other breeds may have been highlighted through the broad search but not 
defined as a case under a specific case definition.  
Other prevalence estimates have been suggested to be as high as 20% prevalence in dogs over 
1 year of age, however this is based on the North American dog population from 1997 
(Johnston, 1997). The methodology of this study used radiographic diagnoses as cases, which 
is often thought of as the definitive diagnostic tool for diagnosing OA, due to the presence of 
new bone formations and abnormal appearances of the joint cartilage (Johnston, 1997). 
However, another study showed evidence of OA on radiographs doesn’t correlate with 
clinical limb function of dogs with OA, which highlights the limitations of a radiographic 
diagnosis only study (Gordon et al., 2003). OA cases may be overestimated in this study due 
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to the appearance of the joint on the radiograph whilst clinical function of the joint may not 
actually be affected and therefore not progressed to OA. Equally however not all changes are 
shown on radiographs, and changes that are shown are not specific to OA so therefore this 
estimate of 20% should be taken with caution (Pettitt and German, 2015).  On another note, 
the prevalence estimate study of 20% is frequently supported and quoted by insurance, 
nutrition and pharmaceutical companies which may have biased attitudes towards the results 
(Johnston et al., 2005). Many nutritional companies tailor prescription diets specifically for 
OA, with many pharmaceutical companies also producing many drugs used in the treatment 
of OA and so a high prevalence would be beneficial and increase custom to these companies. 
From the prevalence estimate (2.5%) in this current study it is expected that in the US 
$3billon a year (annual cost of $1,656 a year per animal) are spent on the management of 
OA, which in the UK would equate to around £200million a year (excluding cost of vet 
examinations and hospital stays) (Bartlett and Van Buren, 2009). This therefore shows the 
importance of this disorder to both the dog and owner highlighting the need for studies in this 
field. 
The current study used both clinical symptomatic OA cases as well as radiographic cases due 
to the fact that radiographs were not used frequently and therefore would have considerably 
underestimated prevalence if relied on alone. This is likely a slightly low estimate due to the 
specificity of the case definition for the study, which meant cases that may well have been 
OA but were not recorded by the vet with the content required for this study were coded as 
non-cases. Further prevalence studies, particularly retrospective cohort longitudinal 
epidemiological studies, would be of benefit to the veterinary field in order to fully identify 
the extent of the disease within the UK dog population.  
Duration of Osteoarthritis 
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Duration of a disease measures the length of time or percentage of life an individual is 
affected by a disease. With some diseases it is an easy measurement, however in the case of 
OA there is difficulty due to the nature of the disorder. As shown in this study, it can occur at 
any age and may go unnoticed until later stages when the dog begins showing signs. This is 
strongly influenced by both the animal and owner, as some individuals are able to mask pain 
more than others and equally some owners are more likely to notice changes to their pet than 
others. This study used a combination of calculations to calculate duration (2 years) and 
percentage of life affected (11%). This was supported by a previous study that found an 
average duration of 2.2 years (Reymond et al., 2012). This is a long time to suffer debilitating 
pain and therefore needs prioritising as a condition in veterinary medicine in order to 
maintain our duty to animal welfare. It was also shown that OA does not only occur in the 
end years of life and can range from 0 to 11 years in duration, which is a serious concern. 
This needs addressing and therefore requires future studies in preventing cases of OA for as 
long as possible in order to reduce its duration. 
Severity of Osteoarthritis 
Another aim of this study was to calculate the severity of OA for the patient. The scale used 
was adapted from previous severity/pain scales as well as proxy measures (Asher et al., 2009, 
Brown et al., 2009, Freeman et al., 2005 and Wiseman-Orr et al., 2006), specific to OA, with 
the aim in future to broaden the scale to be applicable to all disorders using primary care data. 
Four areas (described in Chapter 3) were used to comprise the scale. This included signs of 
disease, treatments, quality of life compromisers and behaviour. Signs of disease and 
behaviour are measures that are exhibited by the animal and therefore can be used to assess 
severity from a non-verbal patient through the way it presents the disease. These also rely on 
the owner recognising them and reporting them to the vet, and the vet recording them. 
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Treatment and compromisers to quality of life demonstrate the vet and owners’ assessment of 
severity. As the observers of the patient, they implement management according to the 
perceived severity of the disease. Severity of OA was found to be greater in overweight 
individuals. This again highlights the importance of education of owners regarding the 
importance of lean dogs in order to reduce the severity of the disease as well as its 
development. The average severity score for the population is 6. With a range of 0 – 13 
which shows there is a wide range in severity between individuals. As previously discussed 
in chapter 3, when compared with severe disorders such as syringomyelia and brachycephalic 
airway obstruction syndrome, the scores for OA fall with the equivalent ranges found by the 
GISID and therefore, the welfare effect of OA on an individual level can be severe and thus 
OA may need to be considered as a disorder of high priority, requiring appropriate 
management according to the individual severity (Asher et al., 2009). Despite a lower 
average score, OA can be of big concern particularly to frequently affected breeds.  
The number of breeds found in this study to have at least 10 individuals affected was 38 (out 
of 156 breeds that had at least one OA case). It has been suggested that those disorders that 
have the greatest welfare impact have the highest severity and prevalence (Collins et al., 
2011). OA can be considered to have moderate severity and prevalence across the entire UK 
dog population (which is likely to be underreported), affects many individual breeds, and is 
likely to have a large impact on canine welfare.  It can therefore be considered as a serious 
concern to canine health.  
It was hypothesised that severity of OA will be affected by age, weight and breed differences 
which was only partly accepted as severity was only significantly affected by weight (i.e. 
overweight individuals who were recommended weight loss), but not by breed group or size, 
or age. 
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Behaviour 
Pain-related behaviour has been previously discussed in the literature (Hansen, 2003) but the 
literature lacks data on behaviours relating to specific conditions. It has also been reported 
that behaviour isn’t discussed frequently in a primary care setting (Roshier and McBride et 
al., 2013a&b). In this current study, 19% of cases had a behavioural change or problem 
mentioned within the EPR ±3 months from the diagnosis of OA.  The actual figure for 
number of dogs with a behaviour problem may be much larger than 19% due to the fact that 
the methodology of this study relies on the owner mentioning behavioural elements during 
their primary care consultation. However, the top three behaviours found associated with OA 
were: quieter than usual, reluctant to exercise and alterations to normal behaviour (which 
involved toileting habits, eating and grooming) which are all absence of routine behaviours. 
Aggression, increase in vocalisations and moodiness were all also reported but less so; these 
are new behaviours that may occur at the onset of a stress trigger such as pain. This suggests 
that owners may be noticing more the changes to routine behaviour and not recognising so 
much new behaviours in their dog that are related to pain, or that many (but not all dogs) 
affected with OA pain respond with a particular behavioural profile. This shows that further 
education is required to owners about the onset of new behaviours that can occur with pain 
causing conditions, as well as to vets to be encouraged to ask about any changes/new 
behaviours in primary care consultations when a pain causing condition is diagnosed. This 
will enable the welfare of the animal to be maintained by treating both the physical and 
psychological element of the disease.  
Conclusion 
This study has demonstrated the prevalence, severity, duration and behaviour of OA in the 
UK dog population. Not only does OA put a massive burden on welfare, but there is an 
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equally as large economic burden associated with the disease. The main risk findings from 
this study show that genetics are a main factor in the development of OA exacerbated through 
lifestyle and environment factors. However, the risk analysis during this study showed that 
crossbreeds are more at risk than certain breed groups and therefore heritability needs to be 
considered in terms wider than simply breed associated screening. The prevalence estimate 
shows that OA needs to be considered more of a priority in vet medicine due to the numbers 
of individuals affected by it. The chronic duration of OA affects welfare of the individual 
outlining the need for studies in prevention to reduce onset and percentage of life affected. 
Severity overall was shown to be moderate and strongly correlated with obesity, emphasising 
the need for better management of overweight dogs, and education to owners on the effect of 
obesity. Finally, this study showed that behaviours associated with OA include that the dogs 
are quieter than normal, reluctant to exercise and may also show more extreme behaviours 
such as aggression. It also showed that behavioural discussions do exist in the EPRs from 
primary care consultations but should continue and increase in order to treat both the physical 
and psychological signs of chronic pain conditions. This study can be used as a tool to 
educate owners of dogs with OA on types of behaviours to look out for and to vets the need 
to engage more in behavioural discussions during consultations. 
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Appendix 
 
Table 1: Search terms used for literature search (156 combinations in total) 
  Species  Disease Key words 
Dog Degenerative joint Disease Risk Factors 
Canine Osteoarth* Predictors 
 Dysplas* Susceptibility 
 Dislocat* Cause 
 Joint fracture Prevalence 
 Ununited anconeal process Incidence 
 luxat*  
 Cruciate ligament  
 Developmental elbow disease  
 Fragmented coronoid process  
 Osteochondrosis  
 Osteochondritis dissecans  
a Example search: Dog AND Dysplas* AND Risk Factors 
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Table 2: Paper Detail Evaluation Criteria 
 
 
 
 
  
Area of Evaluation Answer and Score Awarded 
 Yes No/Not Stated 
Is there a clear research question, aim or 
hypothesis and does the paper design suitably 
answer it with appropriate statistical analysis and 
results stated (values)?  
 
1 0 
Was the study period a suitable time frame? 
 
1 0 
Is the study design relevant to answer the study 
question?  
 
1 0 
Is the research applicable to the target 
population?  
 
1 0 
Are there any other explanations for the 
conclusions discussed? (e.g. other confounding 
variables, result variability due to methods)  
 
1 0 
Does the conclusion fit with other papers? 
 
1 0 
Does the study provide the full picture so that it is 
repeatable?  
 
1 0 
Was there use of controls?  
 
1 0 
Any bias in patient selection? 0 1 (or Y but 
acknowledged) 
Does the research hold any implications (either 
positive or negative)? 
1 0 
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Table 7: Questions asked of the EPR data as part of data extraction 
 
Patients: 
Is the dog an OA case? 
Problem Findings: 
Was osteoarthritis (or synonym) specifically recorded as a final diagnosis? 
Incident or pre-existing in 2013? 
Date of first diagnosis at any time in the clinical records 
Diagnosis 
Was the dog radiographed ± 3 months from the diagnostic episode of care? 
Was there presence of osteophytes? 
Did the dog have a CT ± 3 months from the diagnostic episode of care?  
Single vs. multiple joints affected ± 3 months from the diagnostic episode of care? 
Presenting signs  
Was thickening of the joint (or synonym) recorded  ± 3 months from the diagnostic episode of 
care?  
Was the presence of crepitus (or synonym) recorded ± 3 months from the diagnostic episode of 
care? 
Was limping/lameness recorded ± 3 months from the diagnostic episode of care? 
Was stiffness/reduced range of movement (or synonym) in the effected joint/s recorded ± 3 
months from the diagnostic episode of care? 
Behaviour 
Did the owner report changes in normal behaviours/addition of new behaviours ± 3 months 
from the diagnostic episode of care? 
(Alterations in behaviour include soiling the house, panting, fidgeting, or generalised ‘behaviour 
change’ or ‘acting up’) 
Did the owner report that the dog has become aggressive at home or out of the home (to people 
or other dogs) ± 3 months from the diagnostic episode of care? 
Did the owner report the onset of fears (for example noise fear) ± 3 months from the diagnostic 
episode of care? 
Did the owner report that the dog is reluctant to exercise ± 3 months from the diagnostic episode 
of care? 
Did the owner report that the dog is moody ± 3 months from the diagnostic episode of care? 
Did the owner report that the dog is quieter than before ± 3 months from the diagnostic episode 
of care? 
(Quieter defined as less vocal, lethargic, slower or lack of appetite/thirst 
Did the owner report any increase in vocalisations than before ± 3 months from the diagnostic 
episode of care? 
(Vocalisations defined as howling, whining. Whimpering, yelping and barking) 
Did the owner report that the dog is calmer than before ± 3 months from the diagnostic episode 
of care? 
(Calmer defined as less playful, sleeping more or tires more easily) 
Treatment 
Was at least one veterinary treatment recommended for osteoarthritis at any time in the clinical 
records? 
Was at least one veterinary treatment prescribed/administrated for osteoarthritis at any time in 
the clinical records? 
(Veterinary treatment was defined as any pain relief, diet/weight management, supplement 
nutraceutical, hydro/physiotherapy, laser therapy or acupuncture used to manage the OA)  
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Was at least one analgesic agent recommended for osteoarthritis at any time in the clinical 
records?  
Was at least one analgesic agent prescribed/administered for osteoarthritis at any time in the 
clinical records?  
(Analgesia was defined as any corticosteroids, NSAIDS or Opioids)  
What type of Analgesia type prescribed? (Glucocorticoid, NSAID, Opioid, or combination of 
these)  
Was the analgesia prescribing/administration ± 3 months from the diagnostic episode of care?? 
Was there use of structure-modifying treatments for OA at any time in the clinical records? 
(E.g. cartrophen?) 
Was weight loss/management recommended?  
Was exercise restriction recommended?   
Was surgical intervention/procedure recommended? 
Was surgical intervention/procedure performed?  
Was referral recommended for investigation/therapy?  
Was referral undertaken for investigation/therapy? 
Was the dog on treatment for OA at the final record of OA? 
Final Record information 
Date of final record overall 
Single vs multiple joints affected at end of record for OA? 
Did the dog die during the study?  
Date of death 
Method of death (euth/unassisted/unrecorded) 
Did OA contribute to the death?  
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1) Allowed synonyms for osteoarthritis in EPR: 
-OA/osteoarth 
- Degenerative joint disease/DJD/Joint disease 
-Arthrosis/Osteoarthrosis 
-Arthritis (plus spelling variations) 
- Degenerative arthritis 
-osteophyte/osteophytosis  
-spondylosis 
 
2) Allowed synonyms for clinical management in EPR: 
-NSAID (including: Meloxicam -metacam/meloxidyl, Carprofen- rimadyl, Previcox, Onsior) 
-Strict rest/restrict exercise 
-Weight loss/lose weight 
-cartrophen/fen 
-Tramadol 
-prednisolone 
-glucosamine 
-chondroitin  
-surgery/arthroplasty 
